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ABSTRACT OF DISSERTATION
The Effects of Consumption of California Dried Mission Figs on Serum Lipid
Concentrations in Hyperlipidemic Adults
by
Joycelyn M. Peterson
Doctor of Public Health in Preventive Care
Loma Linda University, Loma Linda, 2011
Serena Tonstad, Chair

Background: The National Cholesterol Education Program and American Heart
Association have recommended the use of functional or cholesterol-reducing foods, some
categories of which include viscous or soluble fibers, soy protein, plant sterols, and nuts,
as aids to reduce serum cholesterol concentrations. Figs are a rich source of viscous fiber
and antioxidants. Fig consumption has not been studied in regard to effects in reducing
serum lipid concentrations. In previous pilot data, increasing fig consumption for six
weeks among volunteers was found to be feasible.
Objective: To evaluate the effect of the consumption of California dried mission
figs on serum lipid concentrations in hyperlipidemic adults.
Research Methods and Procedures: We conducted a randomized controlled
crossover clinical trial on the effects of consumption of California dried mission figs in
men and women aged 30 to 75 years with low-density lipoprotein (LDL) cholesterol
concentrations in the above optimal (100-129 mg/dL), borderline (130-159 mg/dL), or
high (160-189 mg/dL) - if cleared by their physician - range. Participants were recruited
in

from communities in or surrounding San Bernardino, California. The length of the study
was 12 weeks and involved 8 visits: screening between weeks 0 to 2, randomization at
week 2, follow-up at each of weeks 6 and 7 at the end of the first dietary period (after five
weeks of consumption of usual diet or usual diet and figs) and at each of weeks 11 and 12
at the end of the second dietary period (after five weeks of consumption of usual diet or
usual diet and figs) as well as at weeks 4 and 9 for fig pickup and/or a 24-hour dietary
recall.
At screening 141 potentially eligible subjects were informed about the study and
asked to sign informed consent forms. Inclusion and exclusion criteria were checked and
fasting serum lipid concentrations measured. Subjects that met all inclusion criteria
returned within two weeks for randomization. Participants were randomly assigned to
consume their usual diet, or their usual diet plus 40 g of prepackaged and weighed
California dried mission figs with meals three times daily (total of 120 g) for a period of
five weeks, then switched to the other condition for the following five week period. Figs
replaced some desserts and sweet snacks to maintain stable energy consumption.
Participants were asked not to make other changes in their usual diet and physical activity
level for the duration of the study, and consumption of figs outside those provided by the
study or prunes were be allowed. Total and LDL cholesterol, vital signs and
anthropometries were measured at screening and follow-up visits. Mean serum lipid
concentrations at the end of each dietary period (mean of weeks 5 and 6 and mean of
weeks 11 and 12) were compared using paired t-test statistics. Given an estimated 5%
reduction in LDL cholesterol concentration with a standard deviation of 8% we estimated
that to achieve 80% power with a of 0.05, 84 participants were required and 102 were
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randomized. 41 subjects that started with the usual diet had complete blood tests and 43
subjects that started with the figs-added diet had complete blood tests.
Results and Conclusions: The results showed that LDL and HDL cholesterol and
triglyceride concentrations did not differ between usual and figs-added diets (Bonferronicorrected P-values >0.017) while total cholesterol tended to increase with fig
consumption (P=0.02). Total cholesterol increased in participants (n=41) randomized to
usual followed by figs-added diet (p=0.01), but remained unchanged in subjects (n=42)
who started with figs-added followed by usual diet (p=0.4). During the figs-added diet,
soluble fiber intake was 12.6±3.7 g/day versus 8.2±4.1 g/day in the usual diet
(PO.OOOl). Sugar intake increased from 23.4±6.5% of kcalories to 32.2±6.3% of
kcalories in the figs-added diet (PO.OOOl). Body weight did not change (P=0.08).
Thus, daily consumption of figs did not reduce LDL cholesterol. Triglyceride
concentrations were not significantly changed despite an increase in sugar intake.
Significance to Preventive Care: Interventions such as the inclusion of figs in the
usual diet are feasible in a community setting. The judicious use of plant foods is
recommended by Preventive Care Specialists as a simple measure to reduce elevated
serum lipids.
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CHAPTER 1
INTRODUCTION

A. Statement of the Problem
Cardiovascular disease (CVD) continues to be the major health problem and the
leading cause of death in the United States and Canada, claiming one life every 37
seconds (National Center for Health Statistics, 2006). More than a million Americans
experience myocardial infarctions each year, and about a half million people die from
heart disease yearly (U.S. Department of Health and Human Services: U.S. Department
of Agriculture, 2005). Lowering raised serum cholesterol levels is firmly established as
an effective intervention for reducing the mortality and morbidity due to coronary heart
disease (CHD).
Numerous experimental and epidemiological studies have revealed a relationship
between elevated blood lipid values and the development of atherosclerosis (Ross, 1999).
Elevated low density lipoprotein (LDL) cholesterol levels specifically are linked with
atherogenesis and CHD (Behall, Schofield & Hallfrisch, 1997). According to the Expert
Committee on CHD prevention of the World Health Organization, the relationship
between diet, serum cholesterol and coronary disease is a causal one (WHO, 2003). More
than 30% of Americans have undesirably high serum cholesterol concentrations e.g.
greater than 240 mg/dL (Anderson, et al., 2000). Studies have noted that for every 1%
drop in serum cholesterol, there is a decrease of 2% or more in risk of coronary disease
(Key et al., 2003).
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It has been known for decades that polyunsaturated fatty acids lower total and
LDL cholesterol concentrations while saturated fatty acids elevate atherogenic lipids.
Based on these observations, an increase in consumption of monounsaturated and
polyunsaturated fatty acids and a decrease in saturated fats has become the standard
approach of nutritionists and clinicians attempting to improve the blood lipid profile and
decrease the risk of CHD (Ornish et al., 1998). Although these dietary guidelines in
conjunction with various other preventive and intervention procedures have historically
accompanied reduced CHD mortality in the United States, the details of the most suited
dietary fat recommendations to reduce CHD continue to be debated in terms of which
specific fatty acids are most efficacious (Turpeinen et al., 1995).
The American Heart Association (AHA) and the National Cholesterol Education
Program (NCEP) have published recommendations incorporating the scientific rationale
for lowering lipids including total and LDL cholesterol by reducing dietary fat to 30% of
total dietary calories, saturated fat to 7-10% or less and dietary cholesterol to <200-300
mg/dl with carbohydrates making up 50-60% of total calories (Lichtenstein et al., 2006;
Expert Panel, 2001). Plant-based diets are naturally low in saturated fat but rich in
complex carbohydrates and may lower LDL cholesterol substantially (Gardner et al.,
2005). Some researchers have advocated a stringent high carbohydrate, very low fat (less
than 10% of dietary energy) regimen, which has been shown to drastically reduce blood
lipids and promote dissolution of arterial cholesterol deposits and atherosclerotic plaques
(Ornish et al., 1998). On the other hand, guidelines have suggested that up to 35% of total
dietary calories may come from fat, if much of the fat is monounsaturated and
polyunsaturated (U.S. Department of Health and Human Services: U.S. Department of
2

Agriculture, 2005). In this case even diets with less than 50% carbohydrates may induce
positive effects on blood lipid concentrations (Poli et al., 2008).
For many individuals, drug therapy must be started for the achievement of
optimal lipid levels. While drug therapy plays an established role in lowering blood lipids
and inhibiting atherosclerosis, some people do not tolerate certain pharmacotherapies or
may be at too low a risk to receive drug therapy (Jenkins, Kendall & Marchie, 2005a).
Some people may prefer and may benefit more from a dietary approach and may prefer
some foods over others, rather than the use of a pharmacological approach (Behall et al.,
1997). As CHD management costs spiral upwards, prescribing lipid-lowering drugs for
all indicated patients is not always feasible within current resources. Statin-related drugs
may increase the risk for myalgia and liver disorders and some patients have
contraindications to drugs (Larosa et al., 2005).
One of the dietary approaches that are recommended is the incorporation of novel
dietary components shown to reduce blood lipid concentrations. In addition to modifying
the fatty acid composition of the diet, other dietary changes, for example, the inclusion of
certain foods, nutrients or food components may lower blood lipid concentrations. Plant
sterols have been shown to inhibit bile acid and cholesterol absorption, thereby reducing
blood lipid concentrations (Gylling & Miettinen, 1995). Including soy protein in the diet
as a partial replacement of animal protein reduces blood cholesterol levels (Poli et al..
2008). Continued and high interest has been shown concerning the impact of enriching
the diet with foods high in fiber from cereal, grains, vegetables, and fruits (Rimm et al.,
1996).
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Over three decades ago the fiber hypothesis was proposed to explain low rates of
CVD in sub-Saharan Africa (Trowell, 1972). Greater whole grain intakes but not refined
grain intakes are associated with about a one-fifth lower risk of CVD events (Mellen,
Walsh & Herrington, 2008). Numerous studies have confirmed that soluble fiber plays a
role in lowering serum cholesterol (Brown, Rosner Willett & Sacks, 1999). This effect is
more pronounced for soluble or gel-forming fibers found in cereals, such as barley and
oat, and legumes. Furthermore, the most recent guidelines on lowering blood cholesterol
recommend an increased consumption of fiber-rich foods to achieve a total daily intake
of 30 grams per day (Lichtenstein et al., 2006; Expert Panel, 2001). The physicochemical
properties of soluble fiber result in important modifications in volume, bulk and viscosity
in the intestinal lumen, which will alter metabolic pathways of hepatic cholesterol and
lipoprotein metabolism, resulting in lowering of blood LDL cholesterol concentrations
(Fernandez, 2001). B-glucan is the pre-dominant soluble fiber in oats, which has been
shown in a number of studies to lower blood total and LDL cholesterol concentrations.
The mechanism by which B-glucan lowers serum cholesterol levels may be related to its
viscosity, bile salt binding capacity or ability to ferment (Bell et al., 1999). Soluble fiber
including B-glucan does not affect blood concentrations of other lipid fractions including
high density lipoprotein (HDL) cholesterol and triglycerides (Poli et al., 2008).
The Food and Drug Administration (FDA) has permitted health claims for various
plant based foods or food constituents including viscous fiber (oat B-glucan and
psyllium), as well as for soy protein, plant sterols, and most recently, nuts (Jenkins et al.,
2003). The combination of these food ingredients is the dietary equivalent of combining
several cholesterol-lowering drugs and has the potential of drastically lowering blood
4

lipid concentrations (Insel, Turner & Ross, 2007). It is important from a public health
approach to document the cholesterol-lowering effect of a functional food ingredient, and
its mechanism of action under various conditions, such as in combination with
cholesterol-lowering diets (Anderson, Deakins, Floore, Smith & Whittis, 1990). Certain
supplements and foods enriched with these components are on the market in many
countries and may be the basis for new functional foods (Vinson, Zubik, Bose, Samman
& Proch, 2005). Attention should be paid to the beneficial dietary effects and the
potential health risks of such a food ingredient (Jenkins, Kendall & Marchie, 2005b).
The doctoral student has considered, based on her previous experience in clinical
dietetics, that one of the foods that may be effective in lowering blood lipid
concentrations is figs. Figs contain 6-glucan in appreciable amounts in both the fresh and
concentrated form (Rimm et al., 1996; Vinson et al., 2005). Dried fruits like California
mission figs have a greater nutrient density, greater fiber content, increased shelf life and
significantly higher phenol antioxidant content compared to fresh fruit (Vinson et al.,
2005). When figs are diluted in water they become highly soluble, viscous or gummy,
producing an increased intestinal transit time, delayed gastric emptying, and decreased
glucose absorption. Such actions have the potential to lower postprandial blood glucose
concentrations and decrease blood cholesterol (Vinson et al., 2005). It might be helpful in
several ways, including patient preference, to expand the present list of dietary foods rich
in soluble fibers already known to be effective in lowering atherogenic lipid fractions.
Oats, barley and legumes require preparation. Foods that require no preparation like dried
fruit may improve compliance with recommendations to increase soluble fiber in the diet.

5

Presently, a review of PUBMED found no published studies that focus on the
possibility of fig consumption to reduce total or LDL cholesterol concentrations.
B. Purpose of the Study
The purpose of this study is to determine whether dietary consumption of figs is
effective in lowering atherogenic lipid fractions including total and LDL cholesterol.
thereby potentially expanding the list of functional foods that may have a positive effect
on blood lipid concentrations.
C. Research Questions
The following questions will be addressed in this study:
•

Among people with elevated lipid concentrations who are not on drug
therapy for cholesterol, does the daily consumption of California dried
mission figs lower serum total and LDL cholesterol after a period of
five weeks?

•

Is the daily consumption of California dried mission figs feasible and
well tolerated in these individuals for the period of time required to
lower lipid concentrations?

•

What is the effect of daily fig consumption on other lipid fractions
including HDL cholesterol and triglycerides?

D. Significance to Preventive Care
Diet plays a major role in reducing the risk of CHD. This has sparked intensive
research to unravel the role of specific nutrients and foods, to identify dietary patterns
that affect individual risk factors. Over past decades the information obtained has led to a
search for specific foods and food components that may help improve the serum
6

lipoprotein profile. It is important to monitor not only the effects of food components on
the lipoprotein profile but also on other aspects of health. Some people may prefer to
choose a dietary approach rather than a pharmacological one to lowering serum
cholesterol and may benefit more from dietary changes with fewer side effects.
Non-pharmacological dietary interventions such as the inclusion of figs in the
normal diet are feasible in a community setting. If shown to have significant lipid
lowering benefits, such natural dietary products can make an impact on overall health
status and reduce the cost and need for pharmacological treatment (Fernandez, 2001).
The judicious use of dietary foods is recommended by Preventive Care Specialists as a
simple measure to reduce the problem of elevated serum cholesterol. This study might
demonstrate the potential impact that the use of a dietary intervention can have on
lowering serum cholesterol levels and provide a basis for recommendations to the general
population at large if confirmed in future studies.
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CHAPTER 2
LITERATURE REVIEW

A. Lipids: Physiology and Risk
The purpose of this review is to provide an overview of research evaluating
dietary patterns and their effect on blood lipid concentrations, and to review evidence for
specific foods that have demonstrated cardio- protective effects. Collectively, emerging
food-based research in conjunction with our present knowledge of healthful dietary
patterns will provide an impetus for future, well controlled, clinical trials to evaluate
whether inclusion in dietary patterns of specific foods that have been shown to reduce
risk of CVD can be of further benefit.
Lipids refer to substances known as fats and oils, but also to fatlike substances in
foods, such as cholesterol and phospholipids. Dietary sources of lipids include the fats
and oils used in cooking or added to foods, the natural occurring fats in meats and dairy
products, and plant sources such as coconut, olives and avocado. Fat is an essential
nutrient and the body produces and stores fat in the form of triglycerides, however, the
body cannot make some types of fatty acids (a component of triglycerides), so these
compounds must come from the diet. Triglycerides are fats we associate with fried foods,
cream cheese, baked goods, and salad dressing. In the body triglycerides are stored in
fatty tissue. Cholesterol is a waxy substance that is part of all cellular membranes, the
precursor of hormones and involved in triglyceride and fatty soluble vitamin transport in
the blood. Sufficient cholesterol for all needs is produced in the liver, the primary
cholesterol-manufacturing site. The liver produces about 1,000 milligrams per day, and
8

far more than is found in the average diet. Cholesterol is not needed in the diet and only
occurs in foods of animal origin. Its distribution is based on its biological roles: it is
highest in brain, liver, and other organ meats, and moderate in muscle tissue. Since it is
fat soluble, cholesterol is found in the butterfat portion of dairy products. Egg yolks are
high in cholesterol containing about 212 milligrams per large egg (Insel et al., 2007).
When dietary fat is eaten it appears in the bloodstream about one to two hours
later. Digestion breaks down triglycerides into glycerol, free fatty acids, and
monoglycerides. Lipids need special handling to be transported around the body in the
bloodstream. They are packaged into lipoprotein carriers, which have a lipid core of
triglycerides and cholesterol esters surrounded by a shell of phospholipids with
embedded proteins and cholesterol. Carriers from the intestine to the blood are named
chylomicrons. These are rapidly cleared and the triglycerides hydrolyzed. Chylomicron
remnants are what is left, and are taken up by the liver after about 20 minutes of a meal.
The liver assembles very low density lipoproteins (VLDL). VLDL is then transported in
the blood, the triglyceride fraction is hydrolyzed and the cholesterol core that remains is
called LDL. LDL may be taken up by LDL receptors in the liver. A lack of LDL
receptors for example in people with familial hypercholesterolemia reduces the uptake of
cholesterol, forcing it to remain in circulation at dangerously high levels.
Elevated levels of LDL in the blood increase the risk of atherosclerosis and
coronary heart disease, earning LDL cholesterol the nickname ’’bad cholesterol”
(Dietschy, Turkey & Spady, 1993). Dietary saturated fats block LDL receptors, limiting
their clearance of cholesterol from the blood. The receptors also are weakened with age,
and postmenopausally in women. Consumption of tram fats may also lead to elevated
9

LDL cholesterol levels in the blood (Wijendran & Hayes, 2004). Over decades, LDL may
transverse the endothelium lining arteries leading to an accumulation of cholesterol in
macrophages and the development of plaque that thickens and narrows the artery, a
condition known as atherosclerosis (Insel et ah, 2007).
High-density lipoprotein (HDL) is referred to as the “good” cholesterol, because it
carries cholesterol away from arteries and back to the liver where it is then removed from
the body. Levels of HDL cholesterol are inversely associated with CHD (Insel et al.,
2007).
B. Measurement of Lipoproteins and Lipids
Carriers of lipid in the blood including chylomicrons, VLDL, LDL and HDL all
include one or more proteins, called apolipoproteins. Thus the complete lipid and protein
particles are called lipoproteins. Proteins are present in order to solubulize cholesterol in
the blood. Apolipoproteins have a number of enzymatic functions thus modifying and
controlling the metabolism of lipids. Apolipoprotein B is the only protein found in LDL.
VLDL encompasses a number of apolipoproteins, including apolipoproteins B, E and C.
HDL particles are characterized by apolipoprotein A. Apolipoproteins will not be further
discussed in this proposal, but blood will be frozen for the quantification of
apolipoprotein B at a future date.
In clinical and epidemiological research, the entire lipoprotein particle is not
quantified in the laboratory. Total and HDL cholesterol fractions of the particles are
measured, and LDL cholesterol may be measured directly or estimated using a standard
formula. Total cholesterol designates the entire amount of cholesterol in the blood. LDL
cholesterol designates that part of total cholesterol that is carried in the LDL particle and
10

constitutes two thirds or more of total cholesterol. HDL cholesterol designates that part of
total cholesterol that is carried in the HDL particle and constitutes about a fourth of total
cholesterol. Cholesterol in VLDL accounts for the remaining cholesterol (but is not
measured). Triglycerides are found in all particles, but mostly in VLDL. Measured
triglycerides thus include triglycerides found in all particles, VLDL primarily but also
HDL and LDL.
Blood lipids are measured in the fasting condition for the purpose of
standardization. Concentrations of triglycerides are elevated after eating, depending on
the type and amount of food consumed, as well as other factors including genetic ones.
Chylomicrons disappear within a few minutes of eating and are normally not found in the
blood in fasting conditions. Nonfasting conditions influence total and HDL cholesterol
concentrations minimally. Non-HDL cholesterol may be used as a measure of risk, and
includes cholesterol from LDL and VLDL. Non-HDL cholesterol may be measured in
blood samples from nonfasting individuals but is not further discussed here.
C. Modification of Risk Associated with Elevated Blood Lipids
The U.S. Department of Health and Human Services, National Institutes of
Health, National Heart, Lung, and Blood Institute (2001), published a document on high
cholesterol in regard to risk and goals to lower the risk. This appeared in Journal of the
American Medical Association as the Executive Summary of the Third Report of the
NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel III) in 2001 (Expert Panel, 2001). Modified guidelines
were published by the AHA in 2006 (Lichtenstein et al., 2006).
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The appearance of these guidelines signified a new approach to risk modification.
The remarkable progress made in recent years has shown that overall CVD risk is, in
large part, the result of the interplay of multiple risk factors. Not only is the level of total
and LDL cholesterol important, but the presence of other risk factors modifies risk
substantially. Thus, some people with relatively low lipid concentrations may be at
substantially high risk due to the presence of risk factors. When more risk factors that are
present (other than LDL cholesterol), the probability of development of atherosclerosis in
coronary arteries and cardiovascular events increase accordingly. A proportion of the
population are at high risk because of already established CHD or other atherosclerotic
CVD or multiple risk factors that increase the risk to 20% or more over the next 10 years.
Diabetes is also associated with markedly elevated risk. The major risk factors that affect
the level of risk and LDL cholesterol goals of treatment include:
•

Cigarette smoking

•

High blood pressure (140/90 mmHg or higher or taking blood pressure
medication)

•

Low HDL cholesterol (less than 40 mg/dL)

•

Family history of early CHD (CHD in father or brother before age 55 years;
CHD in mother or sister before age 65 years)

•

Age (men 45 years or older; women 55 years or older)

Risk due to these factors is calculated according to Framingham scores. For
educational purposes the various levels of risk may be summarized in Table 2.1.
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Table 2.1 Levels of Risk
If a Person Has
Heart disease, diabetes, or risk score more than 20%*
2 or more risk factors and risk score 10-20%
2 or more risk factors and risk score less than 10%
0 or 1 risk factor

He or She is in Category
I. High Risk
II. Next Highest Risk
III. Moderate Risk
IV. Low-to-Moderate Risk

D. Guidelines for Cholesterol Reduction and Management
The NCEP updated clinical guidelines for cholesterol testing and management for
the treatment of high blood cholesterol in adults is an evidence-based extensively
referenced report that provides the scientific rational for the recommendations to
cholesterol-lowering therapy in clinical practice. These guidelines are intended to inform,
not replace the physician’s clinical judgment, which must ultimately determine the
appropriate treatment for each individual (Expert Panel, 2001).
The first step in selection of LDL lowering therapy is to assess a person’s risk
status as noted above. Risk assessment requires measurement of LDL cholesterol and
other lipids and identification of accompanying risk determinants including cigarette
smoking, hypertension, low HDL cholesterol, family history of premature CHD and age.
Levels of blood lipids are characterized in Table 2.2.
The main goal of cholesterol-lowering treatment is to lower LDL cholesterol
concentration sufficiently to reduce risk. This is accomplished by therapeutic lifestyle
changes (TLC) in all cases and medication in some cases. TLC is for anyone whose LDL
cholesterol level is above goal. Drug treatment is instituted if level of risk is high and
TLC is always recommended together with drug therapy. TLC includes a cholesterol
lowering diet (called the TLC diet), physical activity, and weight management.
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Table 2.2 Levels of Blood Lipids
Total cholesterol
Less than 200 mg/dL
200 to 239 mg/dL
240 mg/dL and up
HDL cholesterol
Less than 40 mg/dL (men)
Less than 50 mg/dL (women)
60 mg/dL and up
LDL cholesterol
Less than 100 mg/dL
100 to 129 mg/dL
130 to 159 mg/dL
160 to 189 mg/dL
190 mg/dL and up
Triglycerides
Less than 150 mg/dL
150 to 199 mg/dL
200 to 499 mg/dL
500 mg/dL and up
Cholesterol ratio (total cholesterol
divided by HDL)
Below 5.0 to 1
3.5 to 1

Desirable
Borderline high
High
Low
Low
High (protective against heart disease)
Optimal
Near or above optimal
Borderline high
High
Very high
Normal
Borderline high
High
Very high

General goal
Optimal level

TLC diet includes the following principles:
•

Reduced saturated fat to <7% of calories, cholesterol <200 mg/day,
increased viscous fiber (10-24 g/day) and plant stand s/sterols (2g/day)
to enhance LDL cholesterol lowering

•

Increased physical activity

•

Weight management

As an example of the amount of lipid reduction that may be achieved with the
dietary recommendations, the be-FIT study in 2000 tested implementing the NCEP diet
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(Walden, Retzlaff, Buck, McCann & Knopp, 2000). This study found that the diet was an
effective therapy in hypercholesterolemic women and men with or without elevated
triglycerides. Subjects were randomized to receive dietary intervention immediately or 6
months later. After 6 months, LDL cholesterol was significantly reduced in women by
7.7% and 8.1%, respectively and in men by 8.8% and 8.1%, respectively (Walden et al.,
2000). No studies have examined the effect of the TLC diet on morbidity and mortality in
randomized controlled clinical trials.
After a collaborated review of recent clinical evidence, the ATP III update that
appeared in 2005 recommended that physicians set a LDL cholesterol goal of less than
1.8 mmol/L (<70 mg/dL) for high risk patients, based on studies such as the Heart
Protection Study. The goals of 130 mg/dL and 160 mg/dL for LDL cholesterol in
moderate and to low-risk individuals remained unchanged (Jenkins et al., 2005b).
In the 2005 Guidelines for Americans a maximum fat intake of 35% of total
calories is recommended (U.S. Department of Health and Human Services: U.S.
Department of Agriculture, 2005). These guidelines also stated that:
•

Saturated fat should supply no more than 10% of total calories

•

Cholesterol intake should be limited to less than 300 milligrams per day.

•

Trans fat intake is to be kept as low as possible.

•

Fiber-rich fruits, vegetables, and whole grains should be chosen often.

In 2006, the AHA released revised diet and lifestyle recommendations
(Lichtenstein et al. 2006; Mozaffarian, Katan, Ascherio, Stampfer & Willett, 2006). One
of the most significant changes from prior guidelines was a recommendation to consume
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at least two weekly servings of oily fish, such as tuna or salmon. The other
recommendations were:
Balance calorie intake and physical activity to achieve or maintain a healthy
weight.
Consume a diet rich in vegetables and fruit.
Choose whole grain, high-fiber foods.
Limit the intake of saturated fat to <7% of energy, trans fat to <1% of energy
and cholesterol to <300 mg per day.
Minimize the intake of beverages and foods with added sugar.
Choose and prepare foods with little or no salt.
If you consume alcohol, do so in moderation.
When you eat food that is prepared outside the home, follow the American
Dietetic Association diet and lifestyle recommendations.
In addition to guidelines in the United States, European and British guidelines for
the management of hypercholesterolemia recommend dietary modification as first-line
therapy and emphasize that soluble fiber lowers serum cholesterol and could therefore
potentially reduce the risk of CHD. It is suggested that treatment guidelines be revised to
include a soluble fiber product as an adjunct to diet for patients where diet alone has
failed and where lifelong therapy with lipid-lowering drugs is inappropriate (MacMahon,
1999).
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E. Soluble Fiber and Lowering of CVD Risk
1. Epidemiological Studies
The association between elevated LDL cholesterol concentrations and
increased risk for CHD has made the scientific community aware of dietary sources that
might effectively reduce blood cholesterol concentrations. Much attention has been given
to the role of dietary fiber intake in the control of lipid and lipoprotein metabolism
(Anderson et ah, 1990). Epidemiological studies have suggested that a diet high in watersoluble fiber is inversely associated with the risk of CVD. Observational studies show a
20 to 40% difference in CHD risk between the highest and lowest fiber intake groups
(Institute of Medicine: Food and Nutrition board, 2005). Observational data from 10
cohort studies suggested that a 10 gram per day increase in dietary fiber was associated
with a 14% lower risk of all coronary events (Pereira et al., 2004). These findings
underlie current dietary recommendations to increase water-soluble fiber intake (Elke et
al., 2008).
In a meta-analysis of observational data from 10 cohort studies on fiber and CVD
risk, Pereira et al. (2004) reported that a diet containing 10 grams per day of dietary fiber
was associated with a 14% lower risk for all coronary risk disorders. Fiber derived from
cereal and fruit sources, and not vegetables, was inversely associated with coronary risk.
Although both insoluble and soluble fiber have been associated with lower risk of CHD
(Pereira et al., 2004), evidence for the association of fiber in reducing coronary risks
appears to be much stronger for soluble than insoluble fiber (Bazzano et al., 2003).
In 2002 the National Academy of Science summarized the results of large,
prospective, epidemiologic studies having a protective effect of dietary fiber against CHD
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and formed the basis for new recommendations for fiber intake. Thus, 38 and 25 grams
per day is recommended for men and women, respectively, for all ages beginning in
youth, based on an intake of 14 g of fiber per 1000 kilocalories (Institute of Medicine
2002).
Data has also appeared indicating that dietary fiber may reduce the risk of stroke.
The Nurses’ Health study showed that women with a high ingestion of whole grains,
fruit, and vegetables had a slightly reduced risk of stroke (Liu et al., 2003). However, the
data from the Atherosclerosis Risk in Communities study were not in line with these
findings (Steffen et al., 2003). Two other studies, the National Health and Nutrition
Examination Survey (NHANES) study, and a Danish study, showed a weak inverse
association between fruit and vegetable fiber ingestion and stroke incidence (Bazzano et
al., 2002; Johnsen at al., 2003).
2. Clinical Studies
Dietary fiber is a collective term which includes a variety of plant
substances, mainly non-starch polysaccharides and lignins, which are resistant to
digestion by digestive enzymes. These can be classified into two groups based on water
solubility. In humans, the structural or matrix fibers (lignins, cellulose, and some
hemicelluloses) are insoluble, and the natural gel-forming fibers (pectins, gums,
mucilages, and the remainder of the hemicelluloses) are soluble (Truswell, 1995). In
contrast to water-insoluble fibers, clinical studies have focused on soluble fibers like oats
and psyllium, pectin and guar gum that may lower blood total and LDL cholesterol
(Glore, Van Treek, Knehans & Guild, 1994).
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More than four decades ago De Groot, Luyken & Pikaar (1963) were the first to
demonstrate that a daily consumption of 300 grams of bread containing 140 grams of
rolled oats, a rich source of soluble fiber, for three weeks resulted in an 11 % decrease in
serum total cholesterol concentration in men. Many trials using oat products were done
thereafter. In a meta-analysis of 12 such trials, Ripsin, Keenan & Jacobs (1992) found
that a daily intake of ~3 grams of soluble fiber from oat products for 18 days to three
months resulted in a modest reduction of total cholesterol concentrations of -0.13
mmol/1. This reduction of total serum cholesterol was seen in both men and women.
Subsequently, Braaten et al. (1994) demonstrated that the cholesterol lowering effect of
oat products can be attributed to their main soluble fiber component, B-glucan. On
January 21, 1997, the FDA approved a health claim on food products which stated, that
“a diet high in soluble fiber from whole oats (oat bran, oatmeal and oat flour) and low in
saturated fat and cholesterol may reduce the risk of heart disease” (FDA, 1997). The
approved amount for health claims was 3 grams of soluble fiber a day. To qualify for the
health claim, the whole oat-containing food must provide at least 0.75 grams of soluble
fiber per serving. The FDA later updated health claims to support barley as a source of
soluble fiber on May 19, 2006. On May 12, 2008 an amendment stated that foods that
could claim to be sources of soluble fiber did not have to be low fat foods.
A meta-analysis subsequent to the FDA health claim (Brown et al., 1999)
included 67 controlled trials. The 67 trials included 25 trials of oat products, 17 of
psyllium, 7 of pectin, and 18 of guar gum. The meta-analysis included 2990 subjects
(1733 men, 1011 women) with an average age of 50 years. The average dose of soluble
fiber was 9.5 grams daily administered over a mean treatment period of 49 days. Fifty19

seven of 67 studies (85%) in the meta-analysis used a control fiber low in soluble fiber,
as wheat bran, cellulose-based placebo, or com flakes.
The effect of soluble fiber in the full dose response range showed that 2-10 grams
per day of soluble fiber significantly reduced total cholesterol by 1.7 mg/dL and LDL
cholesterol by 2.2 mg/dL. Soluble fiber consumption did not significantly affect
triglyceride or HDL cholesterol concentrations (Brown et al., 1999). The various sources
of soluble fiber including oats, psyllium, pectin and guar gum each significantly lowered
total cholesterol and LDL cholesterol respectively as shown in Table 2.3.
Table 2.3 One Gram of Various Sources of Soluble Fiber and Their Effects on Total and
LDL Cholesterol.
Lipid Fraction

-0.070 mmol/L

1 gram guar
gum
-0.026 mmol/L

1 gram pectin

Total

-0.037 mmol/L

1 gram
psyllium
-0.028 mmol/L

Cholesterol

(-1.42 mg/dL)

(-1.10 mg/dL)

(-2.69 mg/dL)

(-1.13 mg/dL)

LDL

-0.032 mmol/L

-0.029 mmol/L

-0.055 mmol/L

-0.033 mmol/L

Cholesterol

(-1.23 mg/dL)

(-1.11 mg/dL)

(-1.96 mg/dL)

(-1.20 mg/dL)

1 gram oats

One gram of soluble fiber from oats, psyllium, pectin or guar gum resulted in
decreased total cholesterol and LDL cholesterol as shown in the table above. When the
meta-analysis was repeated for the practical dose range (£10 g/d) it was found that the
overall effects of fiber were greater compared with the results for the total dose range: 1 g
soluble fiber/d produced a change in total and LDL cholesterol of -0.045 and -0.057
mmol/L (-1.73 and -2.21 mg/dL, respectively). There was no significant dose-response
relation between soluble fiber and changes in HDL-cholesterol or triglyceride
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concentrations. The type of soluble fiber used was not a significant predictor of lipid
changes after the initial lipid concentration was controlled by linear regression. Ripsin et
al. (1992) had reported a more pronounced decrease in serum concentrations of total
cholesterol when baseline concentrations were increased. On the other hand, Brown et al.
(1999) found no evidence that initial serum concentrations of total cholesterol were
related to changes in total cholesterol. However, LDL cholesterol concentrations
decreased significantly more at higher baseline concentrations of LDL cholesterol.
A number of studies that succeeded the 1999 meta-analysis will be reviewed to
illustrate some of the supporting data for this research project. Kris-Etherton et al. (2002)
evaluated 150 moderately hypercholesterolemic men and women 25 to 70 years of age to
understand whether an intervention of foods high in soluble fiber from psyllium and/or
oats (four servings of high fiber foods daily) plus a telephone-based, personalized
behavior change support service of improved serum lipids and elicited cholesterol
managing lifestyle changes vs. usual care. This 7-week study showed that total
cholesterol decreased 5.6%, LDL cholesterol decreased 7.1% and triglycerides 14.2% in
the intervention group (significantly different from the usual care group).
Two studies measured the progression of atherosclerosis in relation to fiber intake
and revealed that viscous fiber showed an inverse relationship to the progression of
carotid atherosclerosis in 40 to 60 year aged men and women without heart disease (Wu
et al., 2003), with higher ingestion of whole-grain foods and cereal fiber associated with
lower progression of coronary atherosclerosis (Erkkila, Herrington, Mozaffarian &
Lichtenstein, 2005).
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Gardner and colleagues performed a four week study in which a complete plantbased diet was provided for participants in the study. This achieved an additional
reduction in the LDL cholesterol level of 4% over the 4.6% reduction in the control group
giving a reduction of nearly 9% in LDL cholesterol from baseline in participants on a
plant-based diet. The greater reduction in serum LDL cholesterol was attributed to the
inclusion of foods with more viscous fiber (41g/2000 kcal vs. 22g/2000 kcal) (Gardner et
al., 2005).
A recent summary of the literature by Like & Mensink (2008) emphasizes that the
importance of increasing the dietary intake of water-soluble dietary fibers is increasingly
recognized. Well-controlled intervention studies have now shown that four major watersoluble fiber types—P-glucan, psyllium, pectin and guar gum—effectively lower serum
LDL cholesterol concentrations, without affecting HDL cholesterol or triglyceride
concentrations. It is estimated that for each additional gram of water-soluble fiber in the
diet serum total and LDL cholesterol concentrations decrease by - 0.028 mmol/L (-1.08
mg/dL) and - 0.029 mmol/L (-1.122 mg/dL), respectively. This would be equivalent to a
5% reduction in total cholesterol from a baseline of 200 mg/dL with the consumption of
10 grams of soluble fiber a day. Despite large differences in molecular structure, no
major differences existed between the different types of water-soluble fiber, suggesting a
common underlying mechanism. It is most likely that water-soluble fibers lower the
(re)absorption of bile acids in particular. As a result hepatic conversion of cholesterol into
bile acids increases, which will ultimately lead to increased LDL uptake by the liver.
The most recent systematic consideration of the relationship between oat
consumption and cholesterol reduction was published in the form of a review by the
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Cochrane Collaboration (Kelly, Summerbell, Brynes & Whittaker, 2007). Three of the
eight oat-based studies selected in the Cochrane review were included in the FDA’s
evaluation of the oat-soluble fiber health claim, and the remaining five studies were
published after 1997. When all eight oat studies were pooled in a meta-analysis, a
significant effect of oat consumption to lower total and LDL cholesterol concentrations
was observed. The reduction in LDL cholesterol from baseline was -4.9% (95%
confidence interval of-7.6% to -2.4%) (Kelly et al., 2007). The review concluded that
“there is surprisingly little evidence available from controlled trials about the effects of
wholegrain foods and diets other than oats and there is a need for studies in this area.”
3. Recommendations
Given this background it is not surprising that both the NCEP and AHA
guidelines recommend an increased consumption of fiber-rich foods to achieve a total
daily intake of 30 grams per day (Lichtenstein et al., 2006; Expert Panel, 2001). The
consumption of 5-10 grams per day of soluble fiber such as |3 glucans, guar and psyllium
reduces blood LDL cholesterol levels by about 5% (Expert Panel, 2001). While fiber
supplements are often touted as a convenient way of achieving this intake, there is no
evidence that supplements achieve the same effects as whole foods (Poll et al., 2008). A
diet rich in vegetables, fruit, whole grains and legumes is supported by a wealth of
evidence, and may work via diverse biological mechanisms to prevent CVD.
F. The fi-Glucan Component of Dietary Fiber
All types of plant foods including fruits, vegetables, legumes and whole grains
contain fiber. Many types of dietary fiber resemble starches, they are polysaccharides, but
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are not digested in the human gastro-intestinal tract. Examples of these nonstarch
polysaccharides include cellulose, hemicellulose, pectins, gums and P-glucan. p-glucans
are polysaccharides of branched glucose units which are found in large amounts in oats
and barley (Insel et ah, 2007). While oats contain around 4% p-glucan, 5-10% p-glucan is
present in barley. Despite its naturally high P-glucan content, barley fiber has been
investigated in fewer trials since barley is less palatable than oats and a less common
dietary component. Nevertheless, the FDA concluded, based on the totality of available
scientific evidence that, whole grain barley and dry milled barley products, such as
flakes, grits, flour, and pearled barley, are appropriate sources of p-glucan water-soluble
fiber to claim that they reduce the risk of CVD (US FDA 2001, 2004).
It has been suggested, however, that the cholesterol-lowering effect of B-glucan
depends on the food matrix or the method of processing of the oat products. For example,
incorporation of B-glucan into oat milk lowered serum concentrations of LDL cholesterol
by 0.063 mmol/L for each gram of B-glucan (Onning et al., 1999). These results
suggested the efficacy of B-glucan preparations increased when they were incorporated
into liquid products.
Brown et al., in their meta-analysis in 1999 found serum concentrations of total
cholesterol decreased significantly by 0.060 mmol/L and those of LDL cholesterol by
0.062 mmol/L, when expressed per gram of B-glucan intake. These decreases were
approximately twice those of 0.037 and 0.032 mmol/L, respectively, for each gram of
soluble fiber intake from oats. This is equal to decreases of about 2 mg/dL and 2.5 mg/dl,
respectively. Subsequently, Naumann et al. (2006) examined the effects of B-glucan-

24

enriched fruit juice on serum lipids and lipoproteins and on markers of cholesterol
absorption (serum concentrations of plant sterols) and synthesis (serum concentrations of
lathosterol). In addition, they measured effects on lipid-soluble antioxidants. Healthy
subjects consumed daily a fruit drink providing 5 g rice starch (control group) or B-glucan
from oats for five weeks (parallel design). Results showed the differences between the
control and B-glucan groups in the change in serum concentrations of total and LDL
cholesterol, respectively, were -4.8% (P = 0.012) and -7.7% (P = 0.005). The differences
between the groups in the change in serum concentrations of lathosterol and sitosterol
were -13% (P = 0.023) and -11% (P = 0.030), respectively. No significant effects were
found on fat-soluble antioxidants. B-glucan lowers serum concentrations of total and
LDL cholesterol when incorporated into a fruit drink. The study concluded that reduced
cholesterol absorption contributes to the cholesterol-lowering effect of B-glucan without
affecting plasma concentrations of lipid-soluble antioxidants (Naumann et al., 2006).
G. Mechanisms of Lipid Lowering by Soluble Fiber
Several mechanisms of action for the hypocholesterolemic effect of soluble fibers
have been suggested. Soluble fiber may increase the binding of the acids in the intestinal
lumen leading to a decreased enterohepatic circulation of bile acids and a subsequent
increase in the hepatic conversion of cholesterol to bile acids (Bell et al., 1999). This has
been demonstrated for psyllium, but not other fiber types (Poli et al., 2008). Soluble fiber
binds bile acids in the gastrointestinal tract, and excretes them in the feces rather than
recycling and reusing them. Additional bile acids must be made from cholesterol, thus
lowering the total amount in the body. In the large intestine, intestinal bacteria partially
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digest fiber and then produce short-chain fatty acids, which are linked to reduced
cholesterol synthesis (Institute of Medicine: Food and Nutrition Board 2005).
Another suggested mechanism of action is that the increased viscosity of the food
mass in the small intestine because of soluble fiber leads to the formation of a thick
unstirred water layer, adjacent to the mucosa, which may act as a physical barrier to
reduce the absorption of nutrients and bile acids (Beer, Arrigoni & Amad’O, 1995).
Furthermore, soluble fiber may reduce the rate of glucose absorption, yielding a lower
glycemic response and lower insulin concentrations, which may later result in a reduced
hepatic cholesterol synthesis (Glore et al., 1994).
High intakes of oat bran was shown to be associated with increased bile acid
synthesis, which increased cholesterol uptake from the circulation and decreased plasma
cholesterol concentrations (Andersson, Ellegard & Andersson, 2002). Oat products have
been reported to decrease the concentrations of small, dense LDL particles which are
considered to be more atherogenic than larger, less dense LDL particles (Lamarche et al.,
1997).
H. Time Course and Choice of Dose
Lifestyle change takes about 3-6 weeks to result in a drop in serum cholesterol
(Brown et al., 1999). Changes in blood lipid concentrations are evident within 3-5 weeks
of TLC (Expert Panel, 2001). The half-life of LDL is 3-4 days, meaning that most LDL
in the blood is gone and replaced by new LDL by about two weeks. So any changes in
diet require at least 2-3 weeks to be reflected in serum lipid levels. In a previous
unpublished pilot study conducted by the doctoral student, the length of time chosen to
see the effect of increased fig consumption on blood lipid concentrations was 6 weeks;
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however, a shorter period of 3-5 weeks is adequate based on lipid physiology. Most
studies have chosen time periods of 4-8 weeks (Brown et al., 1999; Gardner et al., 2005;
Naumann et al., 2006). After eight weeks, LDL cholesterol concentrations remained the
same (FDA, 1997).
The rationale of choice of dose is based on studies in the literature along with the
FDA advisory board which indicated that 3 grams of (3-glucan may lead to a drop in
cholesterol by about 6% after 4 weeks of intervention (FDA, 1997). This study design
provides three servings of figs daily (3-6 grams of soluble fiber/p-glucan). Each serving
of figs (40 grams) provides about 1 -2 grams of B-glucan, yielding a total of 3 grams at the
minimum, if three servings (120 grams) are eaten per day (California Fig Advisory
Board, 2003). Given an expected decrease of about 2 mg/dL and 2.5 mg/dl respectively,
in total and LDL cholesterol per gram of B-glucan (total decreases of 6 mg/dL and 7.5
mg/dL, respectively) as cited by Brown et al. (1999) and an estimated average serum
LDL cholesterol at baseline of about 130 mg/dL, corresponding to a serum total
cholesterol of about 220 mg/dL, the absolute reduction of total and LDL cholesterol
would be about 3% and 6%, respectively.
I. Preparation and Composition of California Mission Figs
Dried fruit are simple and easy to administer. There is no preparation time
needed. The fruit should be served as part of a meal, so that the liquidity of other food
increases the desired effects. A recent study found that figs have the best nutrient score
among the dried fruits when examining calcium, iron, potassium and fiber (Vinson et al.,
2005). California black mission figs (40 grams) provide five grams of fiber which is 20%
of the recommended daily fiber intake, more fiber than two slices of whole grain bread,
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an ounce of almonds, a medium orange, or one half cup of broccoli. As Table 2.4 shows,
of all dried fruits, figs contain the largest amount of dietary fiber.
Table 2.4 Nutritional Information for Raisins, Dates, Dried Figs and Prunes/Plums
Nutrition facts
Serving Size: %
cup (40g)

Raisins
Serving Size: !4
cup (40g)

Dates
Serving Size: 'A
cup (40g)

Dried Figs
Serving Size: Va
cup (40g)

Prunes/Plums
Serving Size: 'A
cup (40g)

Calories 130
Calories from Fat

130 Calories
from Fat 0

120 Calories
from Fat 0

Calories 113
Calories from Fat

Calories 110
Calories from Fat

2

0

% Daily Value
Total Fat Og 0%
Saturated Fat Og

% Daily Value
Total Fat Og 0%
Saturated Fat Og

0

% Daily Value
Total Fat
Saturated Fat
Trans Fat
Cholesterol
Sodium
Total
Carbohydrate

% Daily Value
Total Fat Og 0%
Saturated Fat Og

Protein

Protein Ig

Protein Ig

Protein Ig

Protein Ig

Vitamin A

Vitamin A<2%

Vitamin A 0%

Vitamin A <2%

Vitamin A <5%

Calcium

2%

2%

6%

2%

Vitamin

Vitamin C <2%

Vitamin C <2%

Iron

6%

2%

0%

Trans Fat Og
Cholesterol Omg
0%

% Daily Value
Total Fat Og 0%
Saturated Fat Og
0%

Trans Fat Og
Cholesterol Omg
0%

0%

Trans Fat Og
Cholesterol Omg
0%

0%

Trans Fat Og
Cholesterol Omg
0%

Sodium lOmg

Sodium 0mg0%
Sodium 5mg0% Sodium 5mg 0%
Total
0%
Total
Total
Carbohydrate
Carbohydrate
Carbohydrate
Total
26g 9%
26g 9%
Carbohydrate
31g 10%
________________ 31g 10%_____________________
Dietary Fiber 2g Dietary Fiber 2g Dietary Fiber 3g Dietary Fiber 5g Dietary Fiber 2g
10%
20%
14%
%
8%
Sugars
13g
Sugars
20g
Sugars 29g
Sugars 29g
Sugars

Vitamin C<2%

Vitamin C 4%

6%

6%

Source: www.californiadriedplums.org,www.calraisins.org, and www.califomiafigs
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J. Other Potential Health Benefits
For many years, the concept of the ingestion of high fiber meals has been offered
as an effective manner to reduce the risk of obesity, promote low glycemic food intake
and feelings of satiety (Ball et ah, 2003; Liu et ah, 2003). This aspect of is beyond the
proportions of this proposal.
Saltzman et ah (2001) reported that regardless of whether or not weight is lost,
diets that are high in fiber contribute to a modest decrease in blood pressure. Though this
proposal does not focus on blood pressure, blood pressure will be considered. Lower Creactive protein values have also been reported in conjunction with the consumption of
high fiber diets (King, Egan & Geesey, 2003; Ajani, Ford & Mokdad, 2004). A viscous
fiber intake of 9.8g/l,000 kcalories lowered C-reactive protein concentrations (Jenkins et
ah, 2003) in one study, suggesting that dietary fiber may have anti-inflammatory
properties. Flowever, additional data is needed to provide a clearer understanding of the
potential effect of fiber on C-reactive protein. If financially possible, blood samples may
be frozen for analyses of markers of inflammation in this study.
In a randomized crossover study, 10 non-smoking individuals were assigned to
consume 40 grams of dried mission figs. The control group ingested 240 ml of the soft
drink, Sprite. Blood samples were taken at 0,1,2,4 and 6 hours after consumption. Lunch
was eaten after the 4 hour blood sample. Consumption of mission figs produced a
significant increase in plasma antioxidant capacity for four hours after consumption
compared to the control group (Vinson et ah, 2005). If financially possible, blood
samples may be frozen for analyses of antioxidant capacity in this study.
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K. Conclusions
Diet plays a major role in reducing the risk of CHD. This has led to a search for
specific foods and food components that may help improve the blood lipid profile.
Nutrition research is transitioning an era that began with the study of macronutrients and
micronutrients and now focuses on evaluating food-based approaches, specifically on
identifying foods that maximally reduce risk for CVD. Novel foods that are rich in
soluble fiber may be potentially useful for the purpose of modifying atherogenic blood
lipid concentrations.
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CHAPTER 3
METHODS

A. Overview
Approximately one-half of the adults in the United States have elevated
cholesterol levels (Expert Panel, 2001). The hypothesis of the study is that consumption
of California mission figs may lower serum lipid concentrations. California mission figs
have been reported to contain appreciable amounts of antioxidants plus high levels of
soluble fiber (Vinson et al., 2005; California Fig Advisory Board, 2003). To date, to our
knowledge, no studies have been conducted to study the effect of fig consumption in
lowering serum lipid concentrations. If the consumption of California mission figs is
proven to lower total and LDL cholesterol concentrations, this can make an impact in the
public setting by adding to the list of functional foods that lower serum lipids. Since
studies (Rispin et el., 1992) indicate that 3 grams of soluble fiber have shown to lower
total cholesterol and LDL cholesterol, it would be beneficial to use the same amount or a
similar dosage in this study.
B. Study Design
The California Mission Figs Feeding Trial was a 12 week randomized, crossover
intervention study, which consisted of two phases, intervention and control. Following
screening procedures lasting two weeks, one hundred adult men and women were
randomly assigned to either the intervention or control study phase for the first five
weeks of the trial and then switched to the other phase for the second five weeks of the
trial. During the intervention phase, participants were asked to incorporate a prepackaged,
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pre-weighed 40 gram serving of California mission figs (3-5 figs) at each meal for a total
of three meals a day in their habitual diet for five weeks. Consumption of figs outside of
the packages provided by the study and prune (dried plum) consumption were not
allowed, as prunes are dried fruits that are also rich in soluble fiber. During the control
study phase, participants followed their habitual diet without the consumption of figs or
prunes. Each study participant received a $25.00 honorarium for participating in the
study.

Weeks 2 to 7
Group 1: Habitual diet

Weeks

Week 7 to 12

6 and 7

Mission fig

Weeks
11 and 12

supplemented diet

Group 2: Mission fig
supplemented diet

Habitual diet

Blood draws

Blood draws

Figure 3.1 The Study Design
The Gantt chart and the budget for the study are shown in appendices B and C.
C. Study Participants and Recruitment
141 potential subjects were recruited and screened. Eligible participants were men
and women aged 30 to 75 years with LDL cholesterol concentrations in the following
ranges: above optimal (100-129 mg/dL), borderline (130-159 mg/dL) or high (160-189
mg/dL) - only if given clearance by their physician. Additional inclusion criteria were
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body mass index of 18.5-35 kg/m2, no cigarette smoking within the past 1 year, and
written, informed consent. Exclusion criteria were any secondary cause of hyperlipidemia
(kidney or liver disease, untreated hypothyroidism), current or previous (within the past
two months) use of any lipid-lowering drug, type 1 diabetes or uncontrolled type 2
diabetes (HbAlc > 7%), triglyceride concentrations >300 mg/dL, current or previous
(within the past three months) treatment with estrogen or steroid therapy, stated dislike of
figs, use of certain dietary supplements e.g. Metamucil, sterol/stanol margarine and
others that may have influenced lipid concentrations, chronic disease that may have
affected concentrations of lipids or markers of inflammation (e,g, cancer other than skin
cancer within the last 5 years, chronic rheumatological disease, chronic severe
depression) and any condition deemed by the study investigators to limit compliance with
the protocol (e.g. drug abuse).
Participants were recruited from churches and businesses in communities
surrounding San Bernardino, California. Presentations and flyers about the California
mission fig study were presented at churches and business establishments as well as at the
Drayson Center (gym) at Loma Linda University. Potential subjects were recruited by
flyers approved by the Institutional Review Board. Individuals who filled out the flyer
with their name and phone number were called for an appointment for the screening visit.
Upon arrival at their screening appointment they were provide with explanations of all
study procedures in detail and given the informed consent form (Appendix C). Only
subjects that signed the consent form were allowed to continue with the following
procedures.

33

D. Procedures
1. Weeks 0 to 2 Screening (fasting, if notfasting, one extra visit will be
required within this period)
At the screening visit potential subjects were individually given a detailed
explanation about the purpose of the study and the procedures to be followed during the
course of the 12-week study as described above. The subjects were informed that the only
change required in their regular diet was to be the inclusion of 3-5 dried mission figs
(serving size of 40 grams) to be eaten at each meal three times daily (totaling 120 grams)
seven days a week for a period of five weeks during the intervention phase of the trial.
Consumption of figs outside of this limit or of prunes was not allowed throughout the
study. Informed, written consent was obtained. The study subjects completed a brief
health and physical activity questionnaire (appendix D). Baseline blood samples were
drawn after a 12 hour fasting period at the screening visit, or within 10 days. Vital signs
and anthropometries were measured and recorded.
Potential participants who met the study criteria in regard to the fasting serum
concentrations were contacted by telephone and given an appointment for the week 2
randomization visits which were scheduled within 2 weeks of the screening visit.
2. Week 2 Randomization (fasting not required)
Vital signs and anthropometries were measured and recorded. The study
procedures were reiterated and subjects were asked to complete a short health
questionnaire (appendix E), to check whether any changes had occurred in their health
status or use of medications since the screening visit.
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a. Procedure for Randomization. A random numbers table was used to
generate a list of randomized numbers. Even numbers were designated randomization to
the intervention phase followed by the control phase. Odd numbers were designated
randomization to the control phase followed by the intervention phase. Intervention or
control was written on slips of paper, and these slips were placed in consecutively
numbered opaque envelopes. Subjects were consecutively given a randomization number
corresponding to the numbered envelopes. After assignment of the number, the envelope
was opened, the group assignment noted, and the subject informed.
Subjects randomized to the fig consumption phase (intervention) first received
enough prepackaged fig portions for three weeks of consumption (1 extra week in case
the follow-up visit was delayed). They were instructed not to make any changes in their
habitual diet (with the exception of not eating additional figs or prunes) except as noted
below. They were asked to consume (40 g) of figs three times a day totaling 120 grams,
with meals. Subjects concerned about weight gain were permitted to substitute the figs
for their usual desserts or sweet snacks. If the fig portions were forgotten (e.g. not taken
to work) they could be consumed at a later time in the day with meals or as a snack. Daily
compliance with the assigned portions of figs was recorded on a compliance form
provided (see appendix E).
Subjects randomized to the usual diet phase (control) first were asked to follow
their usual diet (with the exception of not eating figs or prunes).
A telephone interview to obtain a 24-hour dietary recall was performed on a day
chosen randomly between weeks 2 and 4.
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3. Week 4 Follow-up Visit- Fig Pickup for Intervention Group (nonfasting)
Participants who were consuming figs were assigned to attend the study
center to receive the remaining portion of the prepackaged figs for the last three weeks (4
week supply). They were reminded to follow the study protocol and encouraged to ask
any questions and explain any changes that may have affected them while on the study.
Compliance sheets were gathered and new ones were delivered. Those consuming their
usual diet were reminded not to consume any figs or prunes for the remaining next three
weeks.
Subjects were interviewed in person to obtain a 24 hour diet recall. A telephone
interview to obtain a 24-hour dietary recall was performed on a day chosen randomly
between weeks 4 and 6.
4. Week 6 Follow-up Visit (fasting)
Vital signs and anthropometries were measured and recorded. All the
participants in the study had blood samples drawn after a 12 hour fast. Compliance sheets
were gathered from participants consuming figs and new ones were delivered.
5. Week 7 Follow-up Visit (fasting)
Vital signs and anthropometries were measured and recorded. All the
participants in the study had blood samples drawn after a 12 hour fast. Compliance sheets
were gathered from participants consuming figs.
This visit is the crossover visit. Participants who were not eating figs began to
consume 40 g prepackaged figs at each meal three times daily totaling 120 grams, were
given compliance sheets and a three week supply of figs (1 extra week in case of delay of
follow-up appointment). Instructions were given to participants not to consume any other
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dried fruit other than the prepackaged figs or prunes during the subsequent five weeks.
Those concerned about weight gain from the additional 330 kcalories/day from figs, were
advised to substitute the figs for their usual desserts.
Those persons crossing over from figs to their usual diet were reminded not to
consume any figs or prunes for the next five weeks. All subjects completed a brief health
questionnaire (appendix E) that also included fig attitude questions for those just
completing fig consumption.
A telephone interview to obtain a 24-hour dietary recall was performed on a day
chosen randomly between weeks 7 and 9.
6. Week 9 Follow-up Visit- Fig Pick-up for the Intervention Group
(nonfasting)
Participants were assigned to attend the study center to receive the
remaining portion of the prepackaged figs for the last three weeks (4 week supply). They
were reminded to follow the study protocol and encouraged to ask any questions and
explain any changes that affected them while on the study. Compliance sheets were
gathered and new ones delivered.
Those consuming their usual diet were reminded not to consume any figs or
prunes for the remaining next three weeks.
All subjects were interviewed in person to obtain a 24 hour diet recall. A
telephone interview to obtain a 24-hour dietary recall was performed on a day chosen
randomly between weeks 9 and 11.
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7. Week 11 Follow-up Visit (fasting)
Vital signs and anthropometries were measured and recorded. All the
participants in the study had blood samples drawn after a 12 hour fast. Compliance sheets
were gathered from participants consuming figs and new ones were delivered.
8. Week 12 Follow-up Visit (fasting)
Vital signs and anthropometries will be measured and recorded. All the
participants in the study had blood samples drawn after a 12 hour fast. Compliance sheets
were gathered from participants consuming figs. All subjects completed a brief health
questionnaire (appendix E) that also included fig attitude questions for those just
completing fig consumption.
A thank you letter was given to each participant who completed the 12 week fig
research study. Participants were asked to leave their current address (if it was changed
after joining the study) so that the $25.00 check could mailed to them.
E. Procedures for Blood Draws
At each visit involving blood sampling (screening, week 6, week 7, week 11,
week 12), subjects were asked to fast overnight. Water and standard allowed medication
was permitted to be taken on the morning prior to the visit. Blood samples were drawn
between 7:00 to 10:00 AM. At screening one 10 ml red top tube was drawn and
centrifuged. Samples were sent to the Loma Linda University Medical Center Clinical
Laboratory for analysis of total cholesterol, LDL cholesterol, HDL cholesterol and
triglyceride levels as well as ALT, creatinine and glucose. At follow-up visits 6, 7, 11 and
12, one red top tube of 10 ml and one 4 ml purple top tube for plasma were drawn. The
blood was allowed to cool for about 10-15 minutes at room temperature before being put
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on ice. Then samples were placed in a cooler and transported to Nichol Hall Room 1112.
There samples were separated in a refrigerated centrifuge at 1800 x g and 4 degrees
centigrade. Serum/plasma was then drawn by aliquot and placed into vials kept in the -70
freezer in Nichol Hall Room 1112A. Frozen samples for the analysis of lipids were sent
all together at the end of the trial for analysis at the Research Laboratory, University of
California at Davis. The rest of the samples may be used when financing is available for
analysis of apolipoprotein B, C-reactive protein (CRP), markers of endothelial activation
and oxidized LDL (all hypotheses related to lipids and atherosclerosis). Experienced
certified venipuncturists were hired to perform the blood sampling.
F. Measurement of Blood Pressure and Pulse (Vital Signs)
The measurements were taken after the blood tests were completed and
considered part of usual clinical study practice. The following procedure was followed
when taking blood pressure and pulse measurements on all participants.
•

Subjects were seated with back supported and arm bared and supported

•

Subjects refrained from ingesting caffeine for 30 minutes before measurement
were taken.

•

Measurements were begun after at least 5 minutes of rest

•

Appropriate cuff size and calibrated equipment was used

•

Two readings were averaged

•

Pulse was measured for 60 seconds before blood pressure measurement

G. Measurement and Justification of Anthropometries
Moderate weight loss and increased physical activity are important components of
blood lipid control (Poll et al., 2008). These interventions may have lead to declines in
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triacylglyerols and increased HDL cholesterol concentrations. As this study is attempting
to isolate the effect of a single factor, increased soluble fiber consumption, on blood lipid
concentrations, participants were encouraged to maintain a stable weight and not change
physical activity habits. Body weight was monitored.
1. Height and Weight
Subjects’ height was measured (without shoes) using a standard and
calibrated wall stadiometer only at the screening visit. Subjects were weighed using the
Scale-Tronix 5005 stand-on digital scale at screening and visits at weeks 6,7,11 and 12.
This scale is designed for patients up to 600 pounds and was last calibrated November
2007.

2. Weighing-In Procedure
Remove shoes
•

Remove jacket and other outer garments

•

Empty pockets

•

Stand on scale and wait for digital reading and
Record results in the chart

3. Waist Circumference
Waist circumference was measured to the nearest 0.1 cm at the narrowest
level over light clothing, with the use of an unstretched tape measure and without any
pressure to the body surface. Waist was measured at screening and at weeks 7 and 12.
H. Dietary Assessment and Tracking Procedures
Dietary assessment was needed to monitor other changes in the diet than
increased consumption of figs during the intervention phase compared to the control
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phase. This was documented by two phone interviews and 1 in person interview to obtain
dietary information (24 hour diet recall as described in appendix H) on all randomized
participants in each study phase for a total of 6 recalls. The phone interview was
completed on a random day between weeks 2 and 4, 4 and 6, 7 and 9 and 9 and 11. The
day was be chosen by pulling a weekday or weekend day from a box containing Sundays
through Fridays designed on folded papers. The day was returned to the box after being
drawn. If the interview was not possible to have been drawn on the day, it was conducted
as soon as possible thereafter. The in-person interviews were completed on the week 4
and week 9 visits.
The Nutrition Data System for Research (NDSR) which is maintained by the
Nutrition Coordinating Center at the University of Minnesota was the software used to
acquire the 24 hour dietary recall. The recall was performed by registered dietitians who
were blinded to the subject’s group assignment.
Appendix I is a list for the information of the dietitian and study investigators
indicating portions of sweet snacks and desserts that could be substituted by figs.
Appendix J show the dietary recommendations distributed at the beginning of the study
to all participants regarding the NCEP recommended diet for elevated blood cholesterol.
I. Tracking Procedures
On the evening before appointments, participants were called to be reminded
about their appointment and for fasting visits, to be fasting on the morning of the visit.
Text messages were permitted to be used instead of a phone call for appropriate
participants. Participants who missed their scheduled appointments were contacted for a
new appointment if they wished to continue in the study.
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J. Nutritional Analysis of California Mission Figs
California mission figs were obtained from the California Fig Board. An analysis
was performed on California mission figs to determine the amount of soluble and total
fiber present in a serving (40 grams) of figs. The California Fig Advisory Board has
comparison data showing the B-glucan content of mission figs.
K. Data Analysis
Data analysis was conducted by the doctoral student. All data was entered into the
SPSS version 16 database and rechecked. Variables were checked for skewedness and
log transformation was done on skewed variables prior to analysis (e.g. triglyceride was
likely to be skewed).
Data were analyzed by means of comparative tests. Descriptive statistics were
expressed as means and standard deviations for normally distributed variables, and
medians and percentiles for skewed variables. Dietary treatments effects on blood
cholesterol variables were estimated by using mixed linear models, which included a
random factor for the subjects. Statistical analyses were performed with SPSS software
for windows (version 13, Chicago, IL) which assumed the variances and sample sizes
were equal.
The gender distribution of participants and mean values of BMI, waist
circumference, blood pressure, pulse, and lipid concentrations at screening were
presented for each group. Compliance with fig consumption were estimated from the
compliance sheets and subjects that consumed <75% of the assigned figs were designated
as non-compliers, and analysis were performed with and without these participants. Lipid
concentrations at weeks 6 and 7 and at weeks 11 and 12 were averaged to minimize day
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to day variability. The averaged values were presented and analyzed. The percentage
difference for each lipid variable between the intervention and control phases was
calculated.
Dietary data were analyzed and presented. Mean blood pressure, pulse and body
weight measurements at the end of the intervention and control phases were calculated
and presented.
All results were considered significant if the two-tailed P values is <0.05.
Statistical analysis will be performed using SPSS for WINDOWS (SPSS, Chicago, IL).
L. Power Analysis
Since the population parameter s is not known then si and S2 can be used to
calculate a weighted average that estimates s

2_ D?,- 1 QfQ[ii2- m22
+n2-2

The sample size was given a mean expected 5-6% reduction in LDL cholesterol
with an SD of the change of 5-6%. For a mean difference of 5 and SD of 8 using the
equation shown resulted in a sample size of (1.96+0.84)A2*2*64/25=40.1~41 giving a
total sample size of 82. From SPSS output the total sample size requirement for the study
is 84. The power is 80%. If we allow for a dropout rate of up to 20% the final number
for the study was to be 84 + 16 = 100 participants.
M. Strengths and Limitations
The main strength of the study was the randomized, crossover design with
subjects serving as their own controls and the adequate, calculated power. The theoretical
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underpinnings were excellent. As the doctoral students have previously performed a
preliminary study, feasibility seems likely. She had a wide network of potential
participants from the nearby San Bernardino areas. The intervention was simple to
administer to participants. It was simple to administer the intervention phase of the study,
with the inclusion of pre-packaged figs in the habitual diet.
There were also several limitations. Subjects were free living and there was no
control over other food intake. Subjects concerned about weight gain were allowed to
substitute figs for desserts and sweet snacks, which may have lowered lipid
concentrations due to the substitution. The dietary recalls provided data to show whether
the composition of the diet changed between the two periods, other than in regard to
soluble fiber.
Compliance to the study may have been reduced, if the participants’ got tired of
eating figs, though this is unlikely for a period of five weeks. The main limitation was the
lack of dietary counsel to follow AHA and NCEP recommendations for individuals with
elevated cholesterol concentrations. Ideally, subjects would be given dietary instruction
to follow these recommendations prior to inclusion in the study. However, it is feared that
lengthening the study by another 4 weeks would have limited compliance and the number
of blood tests would have been increased. A list of patient recommendations for elevated
cholesterol was given at the initial visit.
N. Research Ethics
Respect was maintained by keeping the information of participants confidential,
not allowing anyone else beside the research group to have access to the personal
information. Data were kept in a database with a password known only to researchers.
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Data were assigned linking codes. All data were stored separately from identifying
information. Only the primary investigator was permitted to have linking access. All data
analyses were conducted on de-identified data. Only trained IRB certified health
professionals were in contact with participants.
Providing participants with the informed consent explaining all the test
procedures and possible side effects or risks, if applicable, was used to maximize benefits
and minimize possible harms. Harms in this study are limited to hematoma,
lightheadedness or other complications of venipuncture.
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Abstract
Background: Figs are a rich source of soluble fiber. We evaluated the effect of
consuming dried California Mission figs on serum lipids in hyperlipidemic adults.
Methods: In a crossover trial men and women aged 30-75 years with elevated LDL
cholesterol (100-189 mg/dL) were randomized to add dried California Mission figs (120
grams/day) to their usual diet for 5 weeks, or eat their usual diet for 5 weeks, then crossed
over to the other condition for another 5 weeks. Six 24-hour dietary recalls were
obtained.
Results: LDL and HDL cholesterol and triglyceride concentrations did not differ
between usual and figs-added diets (Bonferroni-corrected P-values >0.017) while total
cholesterol tended to increase with fig consumption (P=0.02). Total cholesterol increased
in participants (n=41) randomized to usual followed by figs-added diet (p=0.01), but
remained unchanged in subjects (n=42) who started with figs-added followed by usual
diet (p=0.4). During the figs-added diet, soluble fiber intake was 12.6±3.7 g/day versus
8.2±4.1 g/day in the usual diet (PO.OOOl). Sugar intake increased from 23.4±6.5% of
kcalories to 32.2±6.3% of kcalories in the figs-added diet (PO.OOOl). Body weight did
not change (P=0.08).
Conclusions: Daily consumption of figs did not reduce LDL cholesterol. Triglyceride
concentrations were not significantly changed despite an increase in sugar intake.
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Introduction
Elevated low density lipoprotein (LDL) cholesterol concentrations are causally
linked with atherogenesis and coronary heart disease (1,2). One of the dietary
approaches to lower LDL cholesterol is the incorporation of foods with
hypocholesterolemic effects into the daily diet, including fiber, plant sterols, soy protein,
and isoflavones. Numerous studies have established that soluble fiber plays a role in
lowering serum cholesterol [3]. This effect is more pronounced for soluble or gel
forming fibers found in cereals, such as barley and oat, and legumes. Recent guidelines
on lowering blood cholesterol recommend increased consumption of fiber-rich foods to
achieve a total daily intake of 30 grams/day [4-5].
One of the foods that may be effective in lowering blood lipid concentrations is
figs. Figs in both the fresh and dried forms contain soluble fiber in appreciable amounts
[6-7]. Each 100 grams of dried figs provides about Ig of soluble fiber according to a
1999 database [8] but about four times that amount according to Vinson [9]. Dried fruits
like California Mission figs have a greater nutrient density, greater fiber content,
increased shelf life, and significantly higher phenol antioxidant content compared to fresh
fruit [7]. When figs are diluted in water their viscosity increases, and intestinal transit
time may be lengthened, gastric emptying delayed, and glucose absorption decreased.
Such actions have the potential to lower postprandial blood glucose concentrations and
decrease blood cholesterol [7].
Presently, a review of PUBMED found no published studies studying the effect of
fig consumption on reducing serum cholesterol concentrations. In order to evaluate the
effect of the consumption of dried California Mission figs {Ficus carica ‘Mission’) on
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serum lipid concentrations, we conducted a randomized controlled clinical trial in men
and women with LDL cholesterol concentrations in the above optimal to high ranges.
Methods
This was a randomized controlled 2 week screening and 10 week intervention
crossover study conducted at Loma Linda University School of Public Health. The study
was conducted from September through December 2008. The protocol was approved by
the Loma Linda University Institutional Review Board. All subjects provided informed
written consent. Participants were recruited from communities in and surrounding San
Bernardino, California. Information and flyers were presented at churches and business
establishments as well as at the fitness center at Loma Linda University. All subjects
provided background health history information in the form of a brief health
questionnaire.
Participants were women and men ages 30-75 years with LDL cholesterol
concentrations in the above optimal (100-129 mg/dL), borderline (130-159 mg/dL) or
high (160-189 mg/dL) ranges, the latter after clearance by their physician. Additional
inclusion criteria were a body mass index of 18.5-35 kg/m2, and no cigarette smoking
within the past year. Exclusion criteria were any secondary cause of hyperlipidemia
(kidney or liver disease, untreated hypothyroidism); current or previous use (within the
past 2 months) of any lipid-lowering drug; type 1 diabetes or uncontrolled type 2 diabetes
(HbAlc >7%); triglyceride concentrations >300 mg/dL; current or previous treatment
(within the past 3 months) with estrogen or steroid therapy; stated dislike of figs; use of
certain dietary supplements, e.g. Metamucil, sterol/stanol margarine, and others that may
influence lipid concentrations; chronic disease that may affect concentrations of lipids or
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markers of inflammation (e.g. cancer other than skin cancer within the last 5 years,
chronic rheumatological disease, chronic severe depression), and any condition that
would limit compliance with the protocol (e.g. drug abuse).
Following screening procedures, 102 adult men and women were randomly
assigned to either figs-added or their usual diet for the first 5 weeks after randomization
and then switched to the other phase for the second 5 weeks. For randomization the study
coordinator opened opaque pre-numbered envelopes that revealed assignment. During the
figs-added diet, participants were asked to consume a prepackaged, pre-weighed 120
gram serving of dried California Mission figs (12-15 figs) as part of their 3 daily meals
for 5 weeks. Consumption of figs other than those provided by the study and prune (dried
plum) consumption was not allowed. During the usual diet participants followed their
habitual diet but without the consumption of figs or prunes. All participants were given a
list of desserts and sweets to replace with figs in order to maintain stable caloric intake.
Dried California Mission figs were provided by the California Fig Advisory Board.
Study visits were scheduled at weeks 2, 4, 5, 7, 9, and 10 after randomization.
Week 5 was the crossover visit. At each study visit vital signs and anthropometries were
measured. The study procedures were reiterated and subjects completed a short health
questionnaire to check whether any changes had occurred in their health status or use of
medications since the screening visit. If the fig portions were forgotten (e.g. not taken to
work) they were consumed at a later time in the day with meals or as a snack. Daily
compliance with the assigned portions of figs was recorded on a compliance form. A $25
gift certificate was given to each participant who completed the 12 week study.
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Dietary Analyses
Six interviews to obtain 24-hour dietary recalls were performed at week 2 and
onwards; three of these recalls were obtained during the figs-added period and three were
obtained during the usual diet period. The recalls were performed by registered dietitians
and a trained graduate student via two phone interviews and one in-person interview in
each study phase. Two randomly chosen weekdays and one weekend day were targeted in
each period. To select the day the dietitian or student pulled a selection from a box
containing folded papers with the day (Sunday through Friday) for each participant. If the
interview was not possible on the drawn day, it was conducted as soon as possible
thereafter. The Nutrition Data System for Research (NDSR [10]), which is maintained
by the Nutrition Coordinating Center at the University of Minnesota, was the software
used to acquire the 24 hour dietary recall. We also analyzed changes in fiber intake
during the usual diet and fig phases using the Vinson data [9] on the fiber content of dried
figs.
Laboratory Methods
All the participants had blood samples drawn after a 12 hour fast at screening,
and at weeks 4, 5, 9 and 10 after randomization. Water and usual medications were
allowed on the morning prior to the visit. Blood samples were drawn early in the morning
between 6:30 am and 9 am. Samples obtained at screening were sent to the Loma Linda
University Medical Center Clinical Laboratory for analysis of total cholesterol, LDL
cholesterol, HDL cholesterol, and triglyceride levels as well as alanine aminotransferase
(ALT), creatinine, and glucose.
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Blood samples were separated in a refrigerated centrifuge at 1800 x g and 4
degrees centigrade. Serum/plasma was then aliquoted into vials kept in a -70 degree
freezer. Frozen samples were analyzed batchwise at the Research Laboratory at the
University of California at Davis using a Poly-Chem system. Total cholesterol and
triglycerides were measured enzymatically by automated procedures. Two distinct
reaction steps for direct measurements of LDL and HDL cholesterol were conducted: 1.
Elimination of chylomicron, VLDL-cholesterol, and LDL-cholesterol (for HDL
cholesterol) or HDL-cholesterol (for LDL cholesterol) by cholesterol esterase, oxidase,
and catalase; 2. Specific measurement of lipids was done after the release of other lipids
by detergents.
Statistical Analyses
Previous literature indicated a decrease of 0.028 mmol/L (1.1 mg/dL) and 0.029
mml/L (1.1 mg/dL) in total and LDL cholesterol, respectively, for each additional g of
water soluble fiber in the diet. For a daily intake of 120 g of dried figs, the additional
amount of soluble fiber was predicted to be ~4 g/day [9] resulting in about a 4.6 mg/dL
reduction in total and LDL cholesterol. Given the estimated average serum LDL
cholesterol at baseline of about 130 mg/dL, the reduction of LDL cholesterol would be
about 3.5%. With a standard deviation of 8% we estimated that to achieve 80% power
with a of 0.05, 84 participants were required. To allow for an attrition rate of up to 20%,
100 participants were planned.
Following data entry a random sample of 10% was re-entered. A student’s t test or
chi-square analysis, as appropriate, was used to compare participant characteristics.
Lipids at weeks 5 and 10 after randomization were compared by a paired t-test, which
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was also used to compare changes in body weight and diet within each period. Analyses
using the means of weeks 4 and 5 and 9 and 10 did not differ substantially. Comparisons
were also made across groups at the end of each period (Student’s t-test). A general linear
model of repeated measures analysis was done to determine if there were period
treatment interactions (none were found). Because 3 p-values were calculated for each
lipid, the Bonferroni adjustment was used to determine statistical significance. Thus, only
p-values <0.017 were considered statistically significant. Software utilized for analyses
was SPSS version 15.0 (SPSS Inc., Chicago, IL, USA; [11].
Results
Figure 1 shows the flow chart (n=141). Ineligibility for the study was due to too
low LDL cholesterol (n=15); too high LDL cholesterol levels (n=4); too high
triglycerides (n=6); BMI above the cut-off (n=4); BMI below the cut-off (n=l); and lack
of interest in the study (n=9). Thus the total number randomized was 102, of which 51
subjects began with the figs-added diet, and 51 subjects began with the usual diet. There
were 8 participants who dropped out among those initially randomized to the figs-added
diet (3 were lost to follow-up, 1 developed persistent diarrhea, 1 disliked figs, 1 had a
family emergency, 1 was diagnosed with cancer, and 1 started cholesterol-lowering
medication). Among those that started with the usual diet, 6 dropped out (3 were lost to
follow-up, 1 had a family emergency, 1 developed diarrhea, and 1 disliked figs). Of 88
completing subjects, 83 had final blood tests drawn, but 1-3 were missing a specific lipid
value.
Table 4.1 lists the characteristics of participants randomized to usual or to addedfigs diet at screening. They were evenly distributed in relation to demographic,
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anthropometric, and laboratory values. Table 4.2 shows that body weight increased
slightly at the end of the added-figs diet compared to the usual diet with a mean
difference of 0.4 kg, however, this difference did not achieve statistical significance.
Table 4.3 shows the dietary data. There was an increase in energy intake (187±44
kcalories) during the figs-added compared to the usual diet. The percentage of energy
from fat and protein was reduced while the percentage of energy from carbohydrates and
sugar was increased. When examined according to the Vinson (1999) data, there was an
increase in soluble fiber intake in the figs-added diet.
Total cholesterol was 224±45 mg/dL with the usual diet versus 230±41 mg/dL
with the figs-added diet (P=0.021); LDL cholesterol was 127±31 mg/dL with the usual
diet versus 130±27 mg/dL with the figs-added diet (P=0.111); HDL cholesterol was
53±15 mg/dL in both dietary phases (P=1.0); triglycerides were 132±91 mg/dL with the
usual diet versus 135±109 mg/dL with the figs-added diet (P=0.06). However, inspection
of data indicated that the two groups’ lipid concentrations differed. Thus, analyses of
subjects starting with figs-added and switching to usual diet are shown separately from
analyses of subjects starting with usual diet and crossing over to the figs-added diet.
Table 4.4 shows that for subjects who started with figs-added diet, there was no change in
lipid concentrations. However, for subjects that started with the usual and crossed over to
the figs-added diet, there was an increase in total cholesterol and a similar trend in LDL
cholesterol, though not with the Bonferroni correction. Triglyceride and HDL cholesterol
concentrations were unchanged within both groups.
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Discussion
We found no changes in LDL cholesterol concentrations in hyperlipidemic
subjects who added figs to their usual diet, compared to their usual diet alone. HDL
cholesterol levels were also unchanged. The study population was a hyperlipidemic one,
in which any effects of fiber in lower LDL cholesterol would be expected to be manifest.
Foods from sources like oats and barley that are high in soluble fiber significantly lower
LDL cholesterol and thereby total cholesterol [4]. However, oats and barley do not
contain the large amounts of sugar per gram as figs (Table 4.5); despite the increase in
sugar intake triglyceride concentrations did not change significantly.
We are not aware of previous studies examining the effects of dried fruit.
specifically dried California Mission figs, as a source of soluble fiber to lower LDL
cholesterol in hyperlipidemic adults. Our study was planned to expect an approximately
3-4% reduction in LDL cholesterol based on the amount of soluble fiber in dried
California mission figs reported by Vinson in 1999. Though the study power was
adequate, no effect was seen. A number of explanations may be relevant. While
consuming their usual diet, subjects reported that ~59% of energy was from
carbohydrates including almost one-fourth from sugar while <30% of energy was from
fat. Compared to the general population [5], fat intake was lower and carbohydrate intake
was higher, probably reflecting the subjects’ awareness of hypercholesterolemia and
attempts to limit dietary fat. Furthermore, subjects’ intake of dietary fiber was
exceptionally high (mean of 29 grams/day), about double of what is reported by the
general population. Thus, the baseline fiber intake may have been too high for the effects
of moderate amounts of added fiber to be revealed.
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Serum total cholesterol levels increased in the group that began with their usual
diet and crossed over to the figs-added diet, a finding that is not explained by the dietary
changes observed. It is possible that the ~38% increase in sugar intake in the figs-added
diet stimulated very low density lipoprotein (VLDL) synthesis [12]. It is well established
that dietary carbohydrates stimulate hepatic VLDL, and simple carbohydrates have a
great stimulatory effect than complex ones [13]. Increased VLDL may lead to increased
LDL formation and thus, increased total cholesterol levels.
There was no change in HDL cholesterol with fig consumption. Some data have
indicated an effect of dietary fiber on increasing HDL cholesterol, but most studies
indicate that HDL cholesterol concentrations are unchanged [12]. Increased dietary
carbohydrates are associated with decreased HDL cholesterol [12]. Furthermore the
decrease in fat intake, particularly saturated fat intake, with the figs-added diet would be
expected to lower HDL cholesterol. In general, study subjects reported high levels of
physical activity (data not shown) and a number were recruited from the local fitness
center. High levels of physical activity may counteract dietary effects on HDL cholesterol
[14].
The supplemented figs provided about 330 kcalories/day, while the reported diet
showed an increase of 187 kcalories/day, indicating compensatory restriction of other
foods. Over the course of 5 weeks, an increase of 6500 kcalories would be expected to be
associated with a weight increase of about 0.9 kg. The observed weight change was
somewhat smaller and unlikely to cause significant lipid changes.
The strengths of the study include the randomized controlled design, adequately
powered number of participants, and length of follow-up which was sufficient to show
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the tolerability of fig consumption and lipid changes. As LDL cholesterol was measured
directly, we avoided the typical artefactual reduction in LDL cholesterol that is seen
when the Friedewald formula is used to calculate LDL cholesterol in the presence of an
increase in triglycerides. A limitation is that we were unable to obtain adequate blood
samples from all subjects that completed the study. Furthermore, the subjects were free
living, and assessing dietary intake in free living subjects is fraught with threats to
validity, which include underreporting and biased reporting of dietary intakes [15]. The
use of repeated 24-hour recalls is increasingly recommended to avoid limitations on other
methods requiring more effort on the part of the subject [16]. Though the study was
conducted within a short time period to avoid seasonal changes, such effects may have
been present.
In conclusion, consumption of dried figs, despite the high content of soluble
fiber, did not lower serum LDL or total cholesterol concentrations. Paradoxically, an
increase in total cholesterol was observed in the group randomized to usual followed by
figs-added diet. No increase in triglyceride concentrations or lowering of HDL
cholesterol was seen despite the increase in dietary sugar.
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141 Screened
14 Low overall lipid values
6 Triglycerides >300 mg/dL
4 LDL cholesterol too high
8 No longer interested
4 BMI too high
1 BMI too low
1 Family emergency
1 Started hormone therapy

102 Randomized

51 Randomized to usual diet first

51 Randomized to
added figs first
1 Diarrhea
1 Started cholesterol
lowering medication
1 Cancer
1 Family emergency
1 Disliked figs
1 Lost to follow-up

5 Lost to follow-up
1 Family emergency
1 Diarrhea
1 Disliked figs

ir

▼

43 completed (41 with complete final blood tests)

Figure 4.1 Participant Flowchart
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45 completed (42 with
complete final blood
tests)

Table 4.1 Study Participant Characteristics (mean±SD) at Screening for Subjects that
were Randomized to Start with Usual Diet (n=51) versus Subjects that Started with Figs
Added Diet (n=51).

Age (years)

Usual diet

Figs-added

P-value

54.8±11

56.2±10

0.52
0.67

Gender- n (%)
Female

34 (66.7)

36 (70.6)

Male

17(33.3)

15(29.4)
0.49

Ethnicity- n (%)
White

17(33.3)

19(37.3)

Hispanic

13(25.5)

10(19.6)

Caribbean

3 (5.9)

0(0)

Black/Hispanic

0(0)

1(2)

Black

8(15.7)

6(11.8)

Asian

7(13.7)

10(19.6)

Unknown

3 (5.9)

5 (9.8)

Total cholesterol (mg/dL)

205±32

203±27

0.77

Triglycerides (mg/dL)

128±60

113±59

0.20

HDL cholesterol (mg/dL)

55±15

56±13

0.78

LDL cholesterol (mg/dL)

136±23

135±22

0.77

BMI (kg/m2)

25±4

26±3

0.21

TSH (mlU/mL)

2.4± 1.3

2.5±1.4

0.77

Glucose (mg/dL)

93±11

93±13

0.99

Creatinine (mg/dL)

0.9±0.2

0.9±0.3

0.70

ALT (U/L)

21±11

28±15

0.08

Systolic blood pressure (mmHg)

125±19

125±22

0.98

Diastolic blood pressure (mmHg)

79±9

80±10

0.70

Lipid values
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Table 4.2 Anthropometric Data of Participants that Completed the Study at Screening
and at the End of the Figs-Added and Usual Diet Phases. Mean±SD values are shown.

BMI
(kg/m2)
Body
Weight (kg)

Screening
(n=88)
26.4±4.0

Usual diet
(n=85)
26.4±4.0

Figs-added
(n=88)
26.6±4.0

Mean
Difference
-0.2

P-Value*

71.0±13.4

71.0±13.5

71.4±14.0

-0.4

.08

.06

*P values indicate significance level for paired t-tests comparing the end of the figsadded versus usual diet. Body weight was missing for 3subjects at the end of the usual.
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Table 4.3 Nutrient Intake of Study Participants During the Usual Versus Figs-Added
Diets (n=84; data missing for 4 subjects).
Figs-added
SD
Mean

P value

Variable

Usual diet
SD
Mean

Energy (kcalories)

1646

621

1854

695

0.002

29.1

7.6

25.0

7.0

<0.0001

8.1

3.0

6.6

2.8

<0.0001

Polyunsaturated fat 7.8

3.1

6.5

2.3

<0.0001

Monounsaturated fat 10.9

3.6

9.6

3.2

<0.0001

58.5

8.7

64.9

9.0

<0.0001

Sugar

23.4

6.5

32.2

6.3

<0.0001

Protein

15.6

4.7

14.4

3.9

0.008

Fiber, total (grams) 29.0

13.5

37.7

12.4

<0.0001

Cholesterol (mg)

137

114

138

139

0.76

Database

8.2

4.1

8.5

3.2

0.28

Measured
(Vinson 1999)

8.2

4.1

12.6

3.7

<0.0001

% Energy
Fat
Saturated fat

Carbohydrates

Soluble fiber (grams)
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Table 4.4 Serum Lipid Concentrations in Participants Randomized to Figs-Added versus
Usual Diet for 5 Weeks (results of final blood tests shown). Mean±SD values are
shown.*
Period 1 (5 weeks)** Period 2 (5 weeks) •kit it
P value (N=42)
Figs-added
Usual diet
Total cholesterol, mg/dL

231±46

227±34

0.4

HDL cholesterol, mg/dL

53±17

54±14

0.06

Triglycerides, mg/dL

141±132

139±78

0.9

LDL cholesterol, mg/dL

127±22

1.0

Total cholesterol, mg/dL

134±32
Usual diet
215±41

Figs+usual diet
235±48

HDL cholesterol, mg/dL

52±14

55±17

0.1

Triglycerides, mg/dL

131±82

141±131

0.1

LDL cholesterol, mg/dL

119±27

135±32

0.02

P value (N=41)
0.01

*5 participants did not have final blood tests.
**At the end of period 1, lipid values did not differ between the two groups (p=0.1 for total cholesterol;
p=0.9 for HDL cholesterol; p=0.7 for triglycerides; and p=0.02 for LDL cholesterol).
***At the end of period 2, lipid values did not differ between the two groups (p=0.4 for total cholesterol;
p=0.7 for HDL cholesterol; p=0.9 for triglycerides; and p=0.2 for LDL cholesterol).
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Table 4.5 Comparison of Food Sources Rich in Soluble Fiber (per 100 gram)
Energy
(kcal)

Carbohydrate
(g)

Figs, dried, uncooked

249

63.9

47.9

9.8

2.8

Corn flakes

361

87.1

10.5

.7

2.5

Carrots, raw

52

12

6

4

0.8

Apple, fresh

49

16

3.3

3

0.5

Apricots, dried

55

62

41.7

7

0.7

Lentils

116

20.1

1.8

7.9

0.4

Peaches, fresh

50

9

9

1.5

0.7

Prunes, dried

339

62.7

25

7

1.8

Orange, fresh

64

16

13

3

2.6

64

Sugar
(g)

Fiber
(g)

Pectin
(g)
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CHAPTER 5
OTHER FINDINGS

Table 5.1 shows the mean age, gender, lipid values, BMI height and weight of the
participants excluding the dropouts (completers only). The groups are evenly distributed,
except that body weight was slightly higher in the group randomly assigned to consume
figs compared to the than the usual diet group and triglycerides were higher in the usual
diet group than the fig consumption group.
Table 5.1 Descriptives at Baseline Comparing Participants Randomized to Fig versus
Usual Diet Consumption.

Age (years)

Figs (n=45)

Usual diet (n=43) P-value

56.1 (11).

55.2 (12)

.71
.94

Gender
Female

30 (67)

29 (67)

Male

15(33)

14(33)
.40

Ethnicity
White

16(37)

14(31)

Hispanic

7(16)

12(26)

Caribbean

0(.0)

3 (6.9)

Black/Hispanic

1 (2-3)

0(.0)

Black

6(14.0)

7(16)

Asian

9(21)

6(13)

Unknown

4(9.3)

3 (6.7)

Total cholesterol (mg/dL)

204 (30)

202 (27)

.77

Triglycerides (mg/dL)

107 (59)

131 (63)

.08

Lipids at screening
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Table 5.1 (Continued) Descriptives at Baseline Comparing Participants Randomized to
Fig versus Usual Diet Consumption
Figs (n=45)

Usual diet (n=43) P-value

HDL cholesterol (mg/dL)

57 (13)

55 (14)

.51

LDL cholesterol (mg/dL)

133 (22)

135 (23)

.67

161.3(9.5)
71.4(14.0)
27.0(3.3)

161.0(9.3)
71.0(13.5)
25.7(4.0)

.88
.08

Lipids at screening (continued)

Height (cm)
Weight (kg)
BMI (kg/m2)

.11

Table 5.2 shows that of the 235 diet recalls obtained in 80 participants during the
fig consumption phase, the mean amount of figs consumed was 126 grams per dietary
recall, which is just above the target of 120 grams/day. For the 243 diet recalls obtained
in 81 participants during the usual diet phase, the mean amount of figs consumed was
0.19 per diet recall. This indicates excellent compliance with the randomized assignment.
Table 5.2 Average Amount of Figs Consumed per Dietary Recall
Group

Fig consumption group
Usual diet group

Number of
dietary
recalls

Mean amount of
figs consumed
(grams/day)

SD

Median
(grams/day)

235

126
0.19

41
2.17

134

243

0

Table 5.3 shows mean lipid values when the mean of the two final weeks of each
dietary phase is used, rather than the final blood value only, as shown in the publishable
article. The results were very similar to those obtained when only the final values were
used.
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Table 5.3 Serum Lipid Concentrations in Participants Randomized to Fig versus Usual
Diet Consumption for Five Weeks (mean of last two blood tests taken after 4 and 5 weeks
after start of the study phase).

Total cholesterol, mg/dL
HDL cholesterol, mg/dL
Triglycerides, mg/dL
LDL cholesterol, mg/dL
Total cholesterol, mg/dL
HDL cholesterol, mg/dL
Triglycerides, mg/dL
LDL cholesterol, mg/dL

Period 1 (5 weeks)* Period 2 (5 weeks)**
P value (N=45)
Figs+usual diet
Usual diet
0.8
231 (44)
230 (48)
0.06
54(16)
53 (16)
0.2
140(114)
135 (109)
0.5
132 (33)
134 (30)
Figs+usual
diet
P
value
(N=43)
Usual diet
<0.0001***
228 (31)
216(35)
0.02
54(12)
52(13)
0.08
128 (69)
143 (84)
0.001***
127 (22)
120 (23)

Mean (standard deviation) values are shown.
*At the end of period 1, lipid values did not differ between the two groups (p=0.08 for total cholesterol;
p=0.8 for HDL cholesterol; p=0.6 for triglycerides; and p=0.02 for LDL cholesterol).
**At the end of period 2, lipid values did not differ between the two groups (p^O.S for total cholesterol;
p=0.9 for HDL cholesterol; p=0.7 for triglycerides; and p=0.4 for LDL cholesterol).
***Using the Bonferroni correction, only p values <0.017 were considered statistically significant.
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CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS

A. Summary of Findings
Recent research has shown a relationship between high fiber diets and its affect on
body chemistry. A recent report on dietary fiber by the Institute of Medicine (IOM)
suggests that there is a distinction between different types of dietary fiber. For example
functional fiber is soluble, highly viscous, and demonstrates physiological responses to,
but is not limited to maintaining healthy total cholesterol and LDL cholesterol (Carabin et
al, 2009).
Lifestyle changes take about 3-6 weeks to result in a reduction in serum
cholesterol (Brown et al., 1999). Changes in blood lipid concentrations are evident within
3-5 weeks of change of diet. The half-life of LDL is 3-4 days, which suggests that most
LDL in the blood is gone and replaced by new LDL within a two-week period. Dietary
changes require at least 2-3 weeks for changes to be reflected in serum lipid levels
(Expert Panel, 2001). Among the hyperlipidemic adults in this crossover study
consuming California Mission figs for 5 weeks, the mean LDL cholesterol was
unchanged.
Based on the overall findings in the study it appears that the consumption of 40 or
more grams of California mission figs at each meal was not effective at reducing LDL
cholesterol and coronary heart disease risk.
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B. Implications for Preventive Care Practice
The aim of preventive care is to address today’s most pressing health concerns in
public health and promote healthy lifestyles to prevent chronic diseases such as
cardiovascular disease as well as provide effective and cost-saving interventions for
clients and health care providers. Diet and lifestyle are modifiable factors in the
development and prevention of a number of non-communicable diseases, including
cardiovascular disease. It is important from a public health approach to document the
cholesterol-lowering effect of a functional food, whose mechanism of action under
various conditions might provide both effective intervention and cost-savings, as it works
in combination with cholesterol-lowering diets (Anderson, Deakins, Floore, Smith &
Whittis, 1990).
The judicious use of plant foods is recommended by Preventive Care Specialists
as a simple measure to effectively lower elevated serum lipids at a reasonable cost. This
study may provide a basis for recommendations to the general population at large, if
confirmed in future studies. California mission figs are natural dietary products that can
potentially reduce the need for pharmacological treatment, and easily incorporated into
the diet as a functional food because of the potential benefits. The increase of dietary
fiber in the diet also has potentially positive effects on overall health. Dried fruits like
California mission figs have a greater nutrient density, greater fiber content, increased
shelf life and significantly higher phenol antioxidant content compared to fresh fruit
(Vinson et al., 2005). Some people may prefer to choose a dietary approach rather than a
pharmacological one to lowering serum cholesterol and may benefit more from dietary
changes with fewer side effects.
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C. Limitations
Participants were free living without controls over their other food intake.
Those concerned about weight gain may have substituted figs for desserts and sweet
snacks, which may have increased lipid concentrations due to the substitution. The
dietary recalls only gave data showing whether the composition of the diet changed
between the two periods other than in regard to soluble fiber. The primary tools used in
the study, were six 24 hour dietary food records, which are less sensitive when compared
with more reliable methods, such as having assigned dietary meals with the figs prepared
in a metabolic kitchen.
D. Recommendations for Future Study
It is well established that poor dietary practices are linked with major causes of
morbidity and mortality, including cardiovascular disease, hypertension, type 2 diabetes,
overweight and obesity (Dietary Guidelines for Americans 2005). The health and
nutrition paradigm have also changed significantly during the past two decades. Today,
food is not merely viewed as a vehicle for essential nutrients for proper growth and
development, but as a route to optimal wellness (IFIC, 2009). This paradigm of food as
medicine will continue to be driven by several factors including, increased consumer
interest in controlling their health; escalating health care costs advances in biotechnology
and medical technology; nutrigenomics-the study of molecular relationships between
nutrition and the response of genes, with the aim of extrapolating how such subtle
changes can affect human health; and changes in food regulations, which will increase
the need for future evidence-based scientific research linking diet to chronic disease risk
reduction (J Am Diet Assoc. 2009).
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E. Conclusions
Daily consumption of California dried mission figs did not have a significant
effect on lowering serum total and LDL cholesterol after a period of five weeks among
people with elevated lipid concentrations who made no alterations in their regular diet
and are not on drug therapy for lowering cholesterol. Daily consumption of California
dried mission figs was feasible and well tolerated in these individuals for the 5 week
period of time required to lower lipid concentrations. There were no significant changes
in HDL cholesterol. The findings support additional study is warranted on the long-term
use of California mission figs for the lowering of serum cholesterol and the maintenance
of low serum cholesterol levels in the general population.
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INSTITUTIONAL REVIEW BOARD
Initial Approval Notice - Expedited Review

IRB# 58202

OFFICE OF SPONSORED PESEAFiCH -11168 Anderson Street • Lome Linda. CA 92350
1900) 556 4531 (voice) - (900) 5584)131 (lax)

To:

Tonstad, Serena

Department:
Protocol:

Health Promotion & Education
The effects of consumption of California dried mission figs on serum lipid
concentrations in hyperlipidemia adults

This study was review and approved administratively on behalf of the IRB. This decision includes the
following determinations:
Risk to research subjects:
Approval period begins
Stipulations of approval:

Minimal
20-Aug-2008 and ends 19-Aug-2009

Consent Form
Unless IRB has given a specific waiver of informed consent (as documented in the approval stipulations
above) the IRB-approved and stamped consent form accompanies this letter. This now becomes the official
master consent form for making copies to provide to study participants.

Adverse Events / Protocol Changes
The IRB should be notified in writing of any modifications to the approved research protocol. Adverse
effects must be reported to the IRB in accordance with institutional policy. If sponsor or contractual adverse
event reporting requirements differ from requirements for reporting to IRB, all reporting requirements must
still be met.

Protocol Review
Your protocol is tentatively scheduled for review and renewal at least two weeks prior to the approval enddate indicated above. To assure uninterrupted approval of this project, you will be sent a report form to
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time, if applicable.
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following completion of the study.Please note the Pi's name and the IRB number assigned to this IRB
protocol (as indicated above) on any future communications with the IRB. Direct all
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APPENDIX B: INFORMED CONSENT
The Effects of Consumption of California Dried Mission Figs on Serum Lipid
Concentrations in Hyperlipidemic Adults

Purpose and Procedures
You are invited to participate in a research study because your blood cholesterol is not
optimal. The purpose of this study is to identify whether eating California dried mission
figs three times daily with meals for five weeks lowers total cholesterol and low density
lipoprotein (LDL) cholesterol in adults with above optimal, borderline or high cholesterol
levels.
At the first visit you need to be fasting. You will be asked questions about your health
history and your blood lipids, glucose and liver function will be measured. We will check
if you meet the requirements for participation. If you do, we will call you up to arrange
the next visit. At this visit you will be assigned through chance to start eating 1 portion
(1/4 cup) of prepackaged California dried mission figs with your meals three times daily
for 5 weeks OR to continue your usual diet. If you start with the figs, after five weeks you
will return to your usual diet. If you start with your usual diet, after five weeks you will
start eating figs as described above. Figs will be provided at no charge.
The study involves 8 visits in the course of the 12 weeks. The purpose of the visits is to
deliver the figs and take blood tests. All the study visits are required. There will be blood
drawings after 4 and 5 weeks and again after 11 and 12 weeks of the study. This adds up
to a total of 5 blood drawings. At each blood drawing two tubes of blood totaling 5
tablespoons will be obtained. The results of the blood tests after the first one will not be
available until after the end of the study.
We will measure your body weight, waistline and blood pressure at 6 of the 7 study
visits. You will be asked to report your food intake during the last 24 hours on 6
occasions. On 4 of these occasions you will be called up at home by a dietitian for a
telephone report. The other two reports will be done during site visits.
Who can take part
Men and women aged 25 to 75 years with LDL cholesterols that are in the above optimal
(100-129 mg/dL), borderline (130-159 mg/dL) or high (160-189 mg/dL) range can take
part. If your cholesterol is treated with medications you cannot take part. If your
cholesterol is in the high range, we need the permission of your physician. If you have
other diseases that are the cause of your high cholesterol you cannot take part. If you
have type 1 diabetes, type 2 diabetes that is not well controlled or use certain medications
you cannot take part.
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Initials and date:

Risk
Pain and minor bruising at the site of the needle insertion and possible lightheadedness
upon arising after the blood is drawn are possible complications of blood drawing. The
committee at Loma Linda University that reviews human studies (Institutional Review
Board) has determined that participating in this study exposes you to minimal risk.

Benefits
You may not receive any direct benefit from participating in this study. You will be told
your cholesterol levels and receive dietary advice about lowering blood cholesterol. The
dietary changes including figs may lead to lower blood cholesterol. The benefit to
humanity is an understanding of whether a simple dietary change (eating dried figs) can
lower blood cholesterol.

Participants’ Rights
Your participation in this study is voluntary. Your decision whether or not to participate
or terminate at any time will not affect your present or future medical care. If you decide
to stop, please inform the study investigator.
Confidentiality
All of the information that is collected in this study will be kept strictly confidential.
Information that we collect will be assigned linking codes. All this information will be
stored separately from your name and other personal data. Only the primary investigator
will have linking access. Any publication resulting from this study will refer to the
participants as a group.

Additional Costs/Reimbursement
You will be given free figs for the duration of the study. There is no cost to you for
participating in this study. The blood tests will be performed at no cost. There is a modest
monetary compensation of $25.00 for your effort upon completion of the study.

Impartial Third Party Contact
If you wish to contact an impartial third party not associated with this study regarding
any question or complaint you may have about the study, you may contact the Office of
Patient Relations, Loma Linda University Medical Center, Loma Linda, CA 92354, or
call the Office of Patient Relations at (909) 559-4647 for information and assistance.
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Informed Consent Statement
I have read the contents of this consent form, and have listened to the verbal explanation
given by the investigator. My questions concerning this study have been answered to my
satisfaction. I hereby give voluntary consent to participate in this study. This consent
does not waive my rights, nor does it release the investigators, institution, or sponsors
from their responsibilities. I may call the graduate student investigator, Joycelyn M.
Peterson or the faculty advisor, Serena Tonstad, MD PhD at Loma Linda University,
Department of Health Education & Promotion during routine office hours at (909) 5584741 if I have additional questions or concerns. I have been given a copy of this letter for
future reference.
Page 2 of 3

Initials and date:

Subject name (print)

Signature subject

Date

Witness name (print)

Signature witness

Date

I have reviewed the contents of the consent form with the person signing above. I have
explained potential study risks and benefits.

Serena Tonstad, MD PhD
Department of Health
Education & Promotion
Loma Linda University
(909) 558-4575

Joycelyn M., Peterson MPH, RD
Department of Health
Education & Promotion
Loma Linda University
(909) 558-8577

88

APPENDIX C: PARTICIPANT QUESTIONNAIRE (BASELINE)

LOMA LINDA UNIVERSITY
FIG RESEARCH STUDY
Welcome to the fig research study! Please take a few minutes to complete the following
questionnaire. It will be used to facilitate information only and does not represent a
diagnostic evaluation. If you are uncomfortable answering any of these questions, leave
them blank. Thank you for taking the time to fill out this questionnaire.
Date of Birth:

Name:
Gender (please circle): Male or Female

Ethnicity (please circle): Asian, Black (African American or Caribbean), Hispanic,
White
Telephone number:
(Home):

(Work):

(Cell):

Mailing Address:

Email address and fax:
I. Are you under medical care for any of the following conditions or diseases? If yes,
please circle
High blood pressure
arteries)

Angina pectoris (chest pain due to blocked

Stroke

Blocked arteries in legs

Diabetes type 2
arteries

Heart attack or surgery for blocked coronary

Gallbladder disease

Diverticulosis

Irritable bowel syndrome

Heartburn or esophageal reflux

Cancer (write in what type

) Thyroid disease
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High blood cholesterol
Family history of high cholesterol
Food allergies or intolerances (please write in)

Other:

B. Please list all current medications, pain meds, vitamin or other supplements, and over
the counter meds that you are taking at present

C. What has been your highest cholesterol reading?
Approximate date:
What was your most recent cholesterol reading?
Approximate date:
Are you taking medication to lower cholesterol (within the last two months) Circle
Yes or No
D. Do you engage in any regular physical activity? Circle Yes or No
What type and how often?

E. Do you smoke? Circle Yes or No
If yes, for how long and how much
If you quit smoking within the past year, please write the date:
Signature
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APPENDIX D: SHORT HEALTH HISTORY QUESTIONNAIRE
(RANDOMIZATION, CROSSOVER AND FINAL VISIT)
Have there been any changes in your medical condition since the start of the study?
No
Yes
If yes, describe.

Have there been changes in your use of medication since the start pf the study?
No
Yes
If yes, describe.

At crossover or final visit:
On a scale of 1 to 10, with 1 indicating not at all, and 10 indicating very much, how well
do you like eating the provided figs three times a day?
Very much
1 23456789 10
Not at all
Have you noticed any effects of figs on your overall health?
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APPENDIX E: COMPLIANCE SHEET
LOMA LINDA UNIVERSITY SCHOOL OF PUBLIC HEALTH
FIG COMPLIANCE SHEET
Dear Participant,
Please take the time at the end of each day to circle Yes or No for each meal in the boxes
provided below, to indicate whether or not you ate the required amount of figs. Begin at
the first week (one) to the fifth week (five)
Thank you for taking the time to fill out the compliance sheet.
Any questions please call your research interventionist Joy Peterson at 909-261-0359,
or email tojoysfigresearch@yahoo.com
Circle in the box at the end of each day: (Yes) or (No)
Week

Sunday

Monday

Tuesday

Wednesday

Thursday

Friday

Saturday

One
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Two
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Three
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Four
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Five
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No
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APPENDIX F: 24 HOUR DIETARY RECALL
24-Hour Dietary Recall Collection
The NCC Service Center has extensive expertise and experience in conducting 24-hour
dietary recall interviews via telephone with a variety of populations, including children.
Trained and certified NCC staff will train the study dietitian to conduct the 24-hour
dietary recall interviews. Interviews take place over the telephone using NDSR, and are
conducted by Joycelyn Peterson. Because dietary practices have been found to vary by
time of week, interviews are scheduled to capture both weekend and weekday intakes.
The NDSR multiple-pass interview methodology allows the respondent repeated
opportunities to recall their intake within the past 24 hours and to provide detailed food
descriptions. Food portion estimation visual aids are provided to respondents to assist in
portion size estimation.

Contact person is Mary Stevens at 612.626.9428 or
steveQQ4@umn.edu for more information.
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APPENDIX G: COMMON SWEET SNACKS AND DESSERTS
CONTAINING « 330 KCALORIES
Three servings of figs = 330 kcalories
Serving size

Type
Chocolate chip
Oatmeal
Oreo
Pound cake
Brownie
Two fig bars
Apple pie
Carrot cake
Granola bar
Three Musketeers candy bar
Ice cream

4
4
4
3
3
4
4
3

Kcalories
350

oz
oz
oz
oz
oz
oz
oz
oz

360
320
330

350
320
340

350
360
360

6 oz
3 oz
4 oz

420
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APPENDIX I: NCEP DIETARY RECOMMENDATIONS
For people at higher risk, the new (TLC) dietary goals offer dietary
therapy for subgroups of people with specific medical conditions and
risk factors such as these:
•
•
•

high LDL cholesterol or other lipid disorders
coronary heart disease or other cardiovascular disease
diabetes mellitus, insulin resistance or metabolic syndrome

What does the TLC diet recommend?
In May 2001 the NCEP released new guidelines for cholesterol
management. These new guidelines are in the Third Report of the Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel III [ATP III]). The American Heart
Association accepted and endorsed this report and began incorporating
these recommendations into its materials on dietary and lifestyle change
for people with high blood cholesterol.
ATP III recommends that therapy for elevated cholesterol begin with more
intensive life-habit intervention to lower cholesterol and reduce the risk for
developing heart disease and having a heart attack. This approach is
referred to as the “Therapeutic Lifestyle Changes (TLC)” diet. It’s targeted
to people whose LDL cholesterol is above the goal level for their category
of risk for heart disease. These are the essential components of TLC:
Component

Recommendation

LDL-raising nutrients
Saturated fats*

Less than 7% of total calories

Dietary cholesterol

Less than 200 mg/day

Therapeutic options for
LDL-lowering
Plant stanols/sterols

2 grams per day

Increased viscous
(soluble) fiber

10-25 grams per day

Total calories (energy)

Adjust total caloric intake to maintain
desirable body weight/prevent weight gain

Physical activity

Include enough moderate exercise to expend
at least 200 kcal per day

* Trans fatty acids also raise LDL and should be kept at a low intake.
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TLC Diet in ATP HI
Recommended Intake as Percent of Total Calories

Nutrient
Total Fat

1

25-35%

Saturated

Less than 7%

Polyunsaturated

Up to 10%

Monounsaturated Up to 20%
Carbohydrate2

50-60% of total calories

Protein

Approximately 15%

Cholesterol

Less than 200 mg per day

Total Calories3

Balance energy intake and expenditure to maintain
desirable body weight and prevent weight gain

1.

2.

3.
4.

The 25-35% fat recommendation allows for increased intake of
unsaturated fat in place of carbohydrates in people with the
metabolic syndrome or diabetes.
Carbohydrate should come mainly from foods rich in complex
carbohydrates. These include grains (especially whole grains),
fruits and vegetables.
Daily energy expenditure should include at least moderate
physical activity (contributing about 200 Kcal a day).
Options include adding 10-25 grams of viscous (soluble) fiber; 2
g/day of plant-derived sterols or stands. Soy protein may be
used as a replacement for some animal products.

Related AHA publications:
•
•

•

Easy Food Tips for Heart-Healthy Eating (also in Spanish)
"How Can I Cook Healthfully?", "How Do I Follow a Low-Fat
Diet?" and "How Can I Manage My Weight?" in Answers By
Heart kit (also in Spanish kit)
"What About Eating Out?", "How Do I Read Food Labels?", "How
Do I Change Recipes?" and "Why Should I Lose Weight?"
in Answers By Heart kit

Related AHA Scientific Statements
Diet/Nutrition

UNIVERSITY LIBRARIES
LOMA LINDA, CALIFORNIA
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